Gene Symbol | Gene ID | Gene Info |
---|---|---|
Gata3
|
ENSMUSG00000015619.10 | GATA binding protein 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_9875810_9875961 | Gata3 | 486 | 0.644282 | 0.45 | 5.4e-04 | Click! |
chr2_9753821_9753980 | Gata3 | 119772 | 0.039333 | -0.38 | 3.9e-03 | Click! |
chr2_9872860_9873011 | Gata3 | 737 | 0.535200 | -0.31 | 2.4e-02 | Click! |
chr2_9878552_9878744 | Gata3 | 48 | 0.944159 | -0.30 | 2.5e-02 | Click! |
chr2_9879561_9879993 | Gata3 | 1177 | 0.281553 | -0.29 | 3.2e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_100020092_100020385 | 70.03 |
Hnrnpdl |
heterogeneous nuclear ribonucleoprotein D-like |
15830 |
0.13 |
chr1_33630885_33631502 | 52.80 |
Prim2 |
DNA primase, p58 subunit |
7869 |
0.14 |
chr3_152549002_152549525 | 51.62 |
Ak5 |
adenylate kinase 5 |
22511 |
0.2 |
chr1_184648264_184648562 | 36.85 |
Gm37800 |
predicted gene, 37800 |
18940 |
0.14 |
chr11_102891172_102891454 | 36.10 |
Gfap |
glial fibrillary acidic protein |
5818 |
0.1 |
chr6_5155538_5155858 | 28.77 |
Pon1 |
paraoxonase 1 |
38065 |
0.14 |
chr3_103134667_103135106 | 27.50 |
Dennd2c |
DENN/MADD domain containing 2C |
5440 |
0.14 |
chr7_109111039_109111560 | 26.94 |
Ric3 |
RIC3 acetylcholine receptor chaperone |
27968 |
0.13 |
chr3_60602746_60603521 | 26.55 |
Mbnl1 |
muscleblind like splicing factor 1 |
405 |
0.79 |
chr15_80801637_80802005 | 26.37 |
Tnrc6b |
trinucleotide repeat containing 6b |
3106 |
0.28 |
chr7_109595199_109595528 | 25.22 |
Denn2b |
DENN domain containing 2B |
7302 |
0.17 |
chrX_160905132_160905470 | 24.91 |
Gja6 |
gap junction protein, alpha 6 |
1751 |
0.42 |
chr9_48340771_48341057 | 24.89 |
Nxpe2 |
neurexophilin and PC-esterase domain family, member 2 |
16 |
0.98 |
chr15_9114613_9115328 | 24.87 |
Nadk2 |
NAD kinase 2, mitochondrial |
11982 |
0.18 |
chr2_26176816_26176987 | 24.83 |
Gm13553 |
predicted gene 13553 |
14777 |
0.11 |
chr2_131205772_131206168 | 24.53 |
Ap5s1 |
adaptor-related protein 5 complex, sigma 1 subunit |
1108 |
0.33 |
chr17_48451212_48451599 | 24.45 |
Tspo2 |
translocator protein 2 |
87 |
0.95 |
chr8_80500258_80500668 | 24.36 |
Gypa |
glycophorin A |
6682 |
0.24 |
chr7_100502577_100503201 | 23.83 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
4543 |
0.1 |
chr16_93147547_93147854 | 23.82 |
Gm28003 |
predicted gene, 28003 |
74945 |
0.11 |
chr13_76055426_76056750 | 23.56 |
Gpr150 |
G protein-coupled receptor 150 |
908 |
0.49 |
chr6_39203330_39203508 | 23.47 |
Kdm7a |
lysine (K)-specific demethylase 7A |
3370 |
0.19 |
chr1_135941719_135941893 | 22.99 |
Igfn1 |
immunoglobulin-like and fibronectin type III domain containing 1 |
21334 |
0.13 |
chr1_133797348_133797649 | 22.67 |
Atp2b4 |
ATPase, Ca++ transporting, plasma membrane 4 |
3538 |
0.18 |
chr15_12858755_12858923 | 22.66 |
Gm47288 |
predicted gene, 47288 |
16743 |
0.15 |
chr2_121036499_121036885 | 22.48 |
Epb42 |
erythrocyte membrane protein band 4.2 |
11 |
0.96 |
chr2_131827302_131827559 | 22.38 |
Gm14282 |
predicted gene 14282 |
18165 |
0.13 |
chr2_167628701_167629206 | 22.18 |
Ube2v1 |
ubiquitin-conjugating enzyme E2 variant 1 |
3014 |
0.15 |
chr11_6589932_6590111 | 22.03 |
Ccm2 |
cerebral cavernous malformation 2 |
3027 |
0.12 |
chr12_82237150_82237498 | 21.66 |
Sipa1l1 |
signal-induced proliferation-associated 1 like 1 |
19261 |
0.23 |
chr11_109550077_109550245 | 21.63 |
Arsg |
arylsulfatase G |
6407 |
0.18 |
chr7_103865767_103866083 | 21.61 |
Hbb-y |
hemoglobin Y, beta-like embryonic chain |
12709 |
0.06 |
chr11_95808504_95808830 | 21.56 |
Phospho1 |
phosphatase, orphan 1 |
15832 |
0.1 |
chr10_83019507_83019831 | 21.51 |
Gm10773 |
predicted gene 10773 |
12026 |
0.19 |
chr13_95688563_95688884 | 21.46 |
Gm48745 |
predicted gene, 48745 |
3578 |
0.17 |
chr9_98299297_98299586 | 21.27 |
Gm28530 |
predicted gene 28530 |
2209 |
0.3 |
chr4_119028467_119028820 | 21.11 |
Gm12862 |
predicted gene 12862 |
28158 |
0.08 |
chr2_49773578_49773888 | 20.99 |
Lypd6b |
LY6/PLAUR domain containing 6B |
13955 |
0.2 |
chr6_86637547_86637737 | 20.60 |
Asprv1 |
aspartic peptidase, retroviral-like 1 |
9478 |
0.11 |
chr1_86160075_86160340 | 20.41 |
Armc9 |
armadillo repeat containing 9 |
5388 |
0.14 |
chr3_152152491_152152756 | 20.18 |
Gm16198 |
predicted gene 16198 |
824 |
0.51 |
chr2_131454418_131454583 | 19.93 |
Gm14304 |
predicted gene 14304 |
140 |
0.95 |
chr6_116350044_116350568 | 19.85 |
Marchf8 |
membrane associated ring-CH-type finger 8 |
79 |
0.95 |
chr1_195114498_195114763 | 19.31 |
Cr1l |
complement component (3b/4b) receptor 1-like |
3011 |
0.18 |
chr5_22344110_22345571 | 19.30 |
Reln |
reelin |
138 |
0.95 |
chr2_153495771_153496762 | 19.23 |
4930404H24Rik |
RIKEN cDNA 4930404H24 gene |
3476 |
0.22 |
chr11_116506385_116506879 | 19.22 |
Rpl36-ps1 |
ribosomal protein L36, pseudogene 1 |
2096 |
0.17 |
chr10_93731269_93731731 | 19.20 |
Gm15963 |
predicted gene 15963 |
3293 |
0.2 |
chr9_98313593_98313876 | 19.14 |
Gm28530 |
predicted gene 28530 |
12084 |
0.2 |
chr9_64564602_64565217 | 19.10 |
Megf11 |
multiple EGF-like-domains 11 |
18010 |
0.24 |
chr4_36696887_36697086 | 18.96 |
Mir873a |
microRNA 873a |
28400 |
0.17 |
chr1_173333053_173333214 | 18.92 |
Ackr1 |
atypical chemokine receptor 1 (Duffy blood group) |
369 |
0.82 |
chr9_54704347_54704689 | 18.91 |
Mir5710 |
microRNA 5710 |
3795 |
0.15 |
chr11_22182169_22182488 | 18.90 |
Ehbp1 |
EH domain binding protein 1 |
9322 |
0.29 |
chr7_132772857_132773208 | 18.86 |
Fam53b |
family with sequence similarity 53, member B |
3884 |
0.24 |
chr8_123978851_123979300 | 18.75 |
Abcb10 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
4047 |
0.12 |
chr16_93365247_93365596 | 18.67 |
1810053B23Rik |
RIKEN cDNA 1810053B23 gene |
31 |
0.97 |
chr4_151730005_151730352 | 18.63 |
Camta1 |
calmodulin binding transcription activator 1 |
131472 |
0.05 |
chr18_46532039_46532323 | 18.60 |
Fem1c |
fem 1 homolog c |
6210 |
0.15 |
chr1_168287679_168288893 | 18.58 |
Gm37524 |
predicted gene, 37524 |
49385 |
0.16 |
chr15_62159095_62159287 | 18.48 |
Pvt1 |
Pvt1 oncogene |
18984 |
0.25 |
chr16_11423409_11423900 | 18.34 |
Snx29 |
sorting nexin 29 |
2946 |
0.31 |
chr1_53195787_53195974 | 18.27 |
Gm28777 |
predicted gene 28777 |
233 |
0.92 |
chr7_111004187_111004476 | 18.18 |
Mrvi1 |
MRV integration site 1 |
21870 |
0.15 |
chr6_120216773_120216945 | 18.14 |
Ninj2 |
ninjurin 2 |
23036 |
0.17 |
chr14_44034907_44035139 | 18.09 |
Gm3287 |
predicted gene 3287 |
283 |
0.77 |
chr15_62221087_62221407 | 17.97 |
Pvt1 |
Pvt1 oncogene |
1356 |
0.44 |
chr19_55284094_55284395 | 17.92 |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
90 |
0.97 |
chr7_103813259_103814109 | 17.90 |
Hbb-bt |
hemoglobin, beta adult t chain |
312 |
0.71 |
chr9_44336463_44337029 | 17.89 |
Hmbs |
hydroxymethylbilane synthase |
1229 |
0.16 |
chr11_95800592_95800866 | 17.72 |
Phospho1 |
phosphatase, orphan 1 |
23770 |
0.1 |
chr17_71235603_71235900 | 17.66 |
Lpin2 |
lipin 2 |
2911 |
0.23 |
chr12_17506137_17506851 | 17.65 |
Odc1 |
ornithine decarboxylase, structural 1 |
38300 |
0.11 |
chr8_117085550_117085885 | 17.60 |
Pkd1l2 |
polycystic kidney disease 1 like 2 |
3268 |
0.21 |
chr7_25279370_25280622 | 17.56 |
Cic |
capicua transcriptional repressor |
355 |
0.74 |
chr1_184928501_184928704 | 17.50 |
Gm38251 |
predicted gene, 38251 |
5466 |
0.21 |
chr16_49839698_49840015 | 17.39 |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
15510 |
0.24 |
chr9_50811689_50812054 | 17.35 |
Alg9 |
asparagine-linked glycosylation 9 (alpha 1,2 mannosyltransferase) |
3192 |
0.18 |
chr9_95556113_95556470 | 17.29 |
Gm32281 |
predicted gene, 32281 |
941 |
0.46 |
chrX_85614770_85615135 | 17.21 |
Gm44378 |
predicted gene, 44378 |
25975 |
0.18 |
chr4_150523342_150523643 | 17.20 |
Rere |
arginine glutamic acid dipeptide (RE) repeats |
35099 |
0.17 |
chr8_84900828_84901106 | 17.10 |
Klf1 |
Kruppel-like factor 1 (erythroid) |
961 |
0.28 |
chr15_78312445_78312867 | 17.09 |
Csf2rb2 |
colony stimulating factor 2 receptor, beta 2, low-affinity (granulocyte-macrophage) |
6935 |
0.12 |
chr4_93583488_93583704 | 17.07 |
Gm12640 |
predicted gene 12640 |
15590 |
0.19 |
chr18_56870554_56870904 | 17.04 |
Gm18087 |
predicted gene, 18087 |
45359 |
0.14 |
chr8_122685516_122685815 | 17.01 |
Gm15899 |
predicted gene 15899 |
1826 |
0.21 |
chr11_98766610_98767640 | 16.89 |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
3301 |
0.13 |
chr10_59800856_59801208 | 16.87 |
Gm17059 |
predicted gene 17059 |
778 |
0.56 |
chr4_141750503_141750994 | 16.84 |
Agmat |
agmatine ureohydrolase (agmatinase) |
4076 |
0.15 |
chr19_4859385_4859709 | 16.82 |
Ctsf |
cathepsin F |
166 |
0.88 |
chr15_93372828_93373012 | 16.72 |
Zcrb1 |
zinc finger CCHC-type and RNA binding motif 1 |
15224 |
0.16 |
chr1_188831140_188831318 | 16.64 |
Gm25269 |
predicted gene, 25269 |
70753 |
0.12 |
chr5_123094799_123094959 | 16.64 |
Tmem120b |
transmembrane protein 120B |
5022 |
0.1 |
chr2_126165605_126165911 | 16.58 |
Dtwd1 |
DTW domain containing 1 |
11217 |
0.19 |
chr7_24852964_24853147 | 16.58 |
Gm18207 |
predicted gene, 18207 |
7891 |
0.09 |
chr18_56870974_56871252 | 16.52 |
Gm18087 |
predicted gene, 18087 |
44975 |
0.14 |
chr11_49083788_49084231 | 16.44 |
Ifi47 |
interferon gamma inducible protein 47 |
2691 |
0.13 |
chr15_80087812_80088003 | 16.43 |
Gm24204 |
predicted gene, 24204 |
646 |
0.5 |
chr4_132391174_132391454 | 16.40 |
Phactr4 |
phosphatase and actin regulator 4 |
6885 |
0.09 |
chr17_47578693_47578993 | 16.27 |
Ccnd3 |
cyclin D3 |
14593 |
0.11 |
chr1_86160578_86160757 | 16.25 |
Armc9 |
armadillo repeat containing 9 |
5848 |
0.14 |
chr9_120116339_120116545 | 16.23 |
Slc25a38 |
solute carrier family 25, member 38 |
1453 |
0.2 |
chr5_140034121_140034770 | 16.22 |
Gm43702 |
predicted gene 43702 |
2269 |
0.28 |
chr7_34969107_34969361 | 16.20 |
Pepd |
peptidase D |
49 |
0.97 |
chr1_165818578_165818826 | 16.06 |
Gm23402 |
predicted gene, 23402 |
8960 |
0.1 |
chr12_26473166_26473360 | 15.97 |
Cmpk2 |
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial |
667 |
0.64 |
chr13_11924846_11925163 | 15.94 |
Gm26956 |
predicted gene, 26956 |
14554 |
0.25 |
chr7_141132187_141132543 | 15.90 |
Ptdss2 |
phosphatidylserine synthase 2 |
73 |
0.93 |
chr7_135816259_135816526 | 15.89 |
6330420H09Rik |
RIKEN cDNA 6330420H09 gene |
37290 |
0.12 |
chr9_120115481_120115991 | 15.87 |
Slc25a38 |
solute carrier family 25, member 38 |
747 |
0.41 |
chr11_87729488_87729866 | 15.87 |
Rnf43 |
ring finger protein 43 |
303 |
0.8 |
chr2_118662761_118664171 | 15.86 |
Pak6 |
p21 (RAC1) activated kinase 6 |
163 |
0.94 |
chr17_30347161_30347563 | 15.84 |
Btbd9 |
BTB (POZ) domain containing 9 |
12406 |
0.18 |
chr6_38443950_38444228 | 15.83 |
Ubn2 |
ubinuclein 2 |
3556 |
0.2 |
chr1_82825306_82825469 | 15.79 |
Gm17764 |
predicted gene, 17764 |
2526 |
0.14 |
chr5_139382230_139382534 | 15.75 |
Gpr146 |
G protein-coupled receptor 146 |
1801 |
0.22 |
chr4_148204076_148204384 | 15.74 |
Fbxo2 |
F-box protein 2 |
43609 |
0.08 |
chr2_103957767_103958059 | 15.69 |
Lmo2 |
LIM domain only 2 |
73 |
0.96 |
chr1_90281233_90281600 | 15.69 |
Gm28723 |
predicted gene 28723 |
958 |
0.55 |
chr8_31720101_31720377 | 15.69 |
Gm5117 |
predicted gene 5117 |
19521 |
0.24 |
chr13_24551558_24551922 | 15.67 |
Ripor2 |
RHO family interacting cell polarization regulator 2 |
30449 |
0.15 |
chr11_102364651_102365006 | 15.65 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
419 |
0.72 |
chr1_88492536_88492706 | 15.62 |
Glrp1 |
glutamine repeat protein 1 |
17445 |
0.14 |
chr6_72323826_72324126 | 15.61 |
Usp39 |
ubiquitin specific peptidase 39 |
9392 |
0.11 |
chr4_111501532_111501844 | 15.60 |
Agbl4 |
ATP/GTP binding protein-like 4 |
65007 |
0.11 |
chr1_36920168_36920628 | 15.53 |
Gm38115 |
predicted gene, 38115 |
3859 |
0.16 |
chr13_20163704_20164022 | 15.49 |
Elmo1 |
engulfment and cell motility 1 |
21344 |
0.25 |
chr19_47402722_47402937 | 15.48 |
Sh3pxd2a |
SH3 and PX domains 2A |
7530 |
0.23 |
chr5_34924526_34924867 | 15.45 |
Msantd1 |
Myb/SANT-like DNA-binding domain containing 1 |
7157 |
0.18 |
chr12_12428967_12429271 | 15.39 |
4921511I17Rik |
RIKEN cDNA 4921511I17 gene |
36504 |
0.21 |
chr10_69910043_69910940 | 15.38 |
Ank3 |
ankyrin 3, epithelial |
4374 |
0.35 |
chr9_66894964_66895296 | 15.35 |
Rab8b |
RAB8B, member RAS oncogene family |
24557 |
0.13 |
chr11_62605415_62606716 | 15.34 |
Lrrc75aos2 |
leucine rich repeat containing 75A, opposite strand 2 |
298 |
0.72 |
chr9_45776338_45776549 | 15.28 |
Cep164 |
centrosomal protein 164 |
3912 |
0.16 |
chr11_109517832_109518132 | 15.28 |
Gm22378 |
predicted gene, 22378 |
18158 |
0.13 |
chr16_96918984_96919312 | 15.28 |
Gm32432 |
predicted gene, 32432 |
391 |
0.92 |
chr5_146280774_146281063 | 15.24 |
Cdk8 |
cyclin-dependent kinase 8 |
5258 |
0.17 |
chr4_123286770_123287029 | 15.23 |
Pabpc4 |
poly(A) binding protein, cytoplasmic 4 |
3804 |
0.11 |
chr7_66113642_66113961 | 15.19 |
Chsy1 |
chondroitin sulfate synthase 1 |
4286 |
0.13 |
chr12_110549812_110550100 | 15.16 |
B930059L03Rik |
RIKEN cDNA B930059L03 gene |
40556 |
0.1 |
chr11_8972169_8972371 | 15.12 |
Pkd1l1 |
polycystic kidney disease 1 like 1 |
996 |
0.58 |
chr8_123990516_123990684 | 15.00 |
Abcb10 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
7478 |
0.1 |
chr19_17337368_17337645 | 15.00 |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
2062 |
0.37 |
chrX_42019468_42019889 | 14.98 |
Xiap |
X-linked inhibitor of apoptosis |
40001 |
0.15 |
chr5_121236574_121236747 | 14.97 |
Hectd4 |
HECT domain E3 ubiquitin protein ligase 4 |
16441 |
0.13 |
chr9_90249129_90249296 | 14.97 |
Tbc1d2b |
TBC1 domain family, member 2B |
6715 |
0.18 |
chr9_45274436_45274643 | 14.97 |
Il10ra |
interleukin 10 receptor, alpha |
5390 |
0.11 |
chr3_144598637_144599169 | 14.97 |
Selenof |
selenoprotein F |
8478 |
0.14 |
chr18_32556691_32557012 | 14.96 |
Gypc |
glycophorin C |
3129 |
0.27 |
chr7_110715161_110715448 | 14.89 |
Gm18907 |
predicted gene, 18907 |
1907 |
0.28 |
chr13_45849210_45849500 | 14.89 |
Atxn1 |
ataxin 1 |
22933 |
0.23 |
chr13_112816068_112816355 | 14.83 |
Plpp1 |
phospholipid phosphatase 1 |
15348 |
0.15 |
chr11_11742612_11742931 | 14.81 |
Gm12000 |
predicted gene 12000 |
46332 |
0.11 |
chr4_115856193_115856618 | 14.79 |
Mknk1 |
MAP kinase-interacting serine/threonine kinase 1 |
627 |
0.61 |
chr2_172260059_172260339 | 14.74 |
Mc3r |
melanocortin 3 receptor |
11707 |
0.17 |
chr16_76313975_76314295 | 14.73 |
Nrip1 |
nuclear receptor interacting protein 1 |
9523 |
0.25 |
chr3_68975957_68976133 | 14.71 |
Ift80 |
intraflagellar transport 80 |
2300 |
0.2 |
chr17_10042362_10042539 | 14.69 |
Gm49809 |
predicted gene, 49809 |
94613 |
0.08 |
chr17_25943201_25943527 | 14.68 |
Pigq |
phosphatidylinositol glycan anchor biosynthesis, class Q |
502 |
0.51 |
chr9_72409226_72409810 | 14.64 |
Gm27255 |
predicted gene 27255 |
250 |
0.55 |
chr6_60828850_60829656 | 14.61 |
Snca |
synuclein, alpha |
249 |
0.93 |
chr11_58351240_58351509 | 14.52 |
Sh3bp5l |
SH3 binding domain protein 5 like |
6062 |
0.1 |
chr13_73500167_73500681 | 14.50 |
Lpcat1 |
lysophosphatidylcholine acyltransferase 1 |
2437 |
0.31 |
chr12_105016395_105016591 | 14.48 |
Gm47648 |
predicted gene, 47648 |
4866 |
0.11 |
chr6_116350734_116350997 | 14.48 |
Marchf8 |
membrane associated ring-CH-type finger 8 |
27 |
0.96 |
chr11_97427734_97428829 | 14.45 |
Arhgap23 |
Rho GTPase activating protein 23 |
8004 |
0.16 |
chr9_45776606_45776801 | 14.44 |
Cep164 |
centrosomal protein 164 |
4172 |
0.16 |
chr13_73475366_73476070 | 14.43 |
Lpcat1 |
lysophosphatidylcholine acyltransferase 1 |
3967 |
0.26 |
chr13_107100851_107101138 | 14.38 |
Gm31452 |
predicted gene, 31452 |
37299 |
0.14 |
chr4_49451851_49452103 | 14.38 |
Acnat1 |
acyl-coenzyme A amino acid N-acyltransferase 1 |
840 |
0.52 |
chr7_135721881_135722214 | 14.35 |
Mki67 |
antigen identified by monoclonal antibody Ki 67 |
5686 |
0.18 |
chr18_21152420_21152758 | 14.33 |
Gm6378 |
predicted pseudogene 6378 |
75480 |
0.09 |
chr1_174428495_174428651 | 14.31 |
Olfr414 |
olfactory receptor 414 |
1857 |
0.29 |
chr6_83015153_83015532 | 14.30 |
M1ap |
meiosis 1 associated protein |
10996 |
0.07 |
chr10_40149754_40150093 | 14.30 |
Slc16a10 |
solute carrier family 16 (monocarboxylic acid transporters), member 10 |
7665 |
0.13 |
chr2_167141763_167142137 | 14.29 |
Kcnb1 |
potassium voltage gated channel, Shab-related subfamily, member 1 |
40124 |
0.08 |
chr12_83302133_83303175 | 14.27 |
Dpf3 |
D4, zinc and double PHD fingers, family 3 |
8226 |
0.28 |
chr11_44509325_44509652 | 14.26 |
Rnf145 |
ring finger protein 145 |
9476 |
0.16 |
chr7_4749090_4749534 | 14.25 |
Cox6b2 |
cytochrome c oxidase subunit 6B2 |
3216 |
0.09 |
chrX_56446670_56446966 | 14.25 |
Gm2174 |
predicted gene 2174 |
1147 |
0.35 |
chr7_16340726_16341001 | 14.19 |
Bbc3 |
BCL2 binding component 3 |
27346 |
0.09 |
chr7_55981650_55981809 | 14.19 |
Gm15888 |
predicted gene 15888 |
1802 |
0.19 |
chr5_118480054_118480344 | 14.17 |
Gm15754 |
predicted gene 15754 |
6768 |
0.21 |
chr2_78718517_78718735 | 14.13 |
Gm14463 |
predicted gene 14463 |
61197 |
0.13 |
chr11_101010467_101010728 | 14.10 |
Atp6v0a1 |
ATPase, H+ transporting, lysosomal V0 subunit A1 |
60 |
0.96 |
chr4_58970722_58971018 | 14.08 |
Ptgr1 |
prostaglandin reductase 1 |
16249 |
0.12 |
chr18_41942850_41943121 | 14.03 |
Prelid2 |
PRELI domain containing 2 |
8209 |
0.21 |
chr12_105026209_105026535 | 14.02 |
Gm47650 |
predicted gene, 47650 |
1591 |
0.21 |
chr18_75490269_75490434 | 14.00 |
Gm10532 |
predicted gene 10532 |
24294 |
0.23 |
chr4_154020712_154021162 | 14.00 |
Lrrc47 |
leucine rich repeat containing 47 |
1298 |
0.27 |
chr5_139804575_139804999 | 13.99 |
Tmem184a |
transmembrane protein 184a |
3193 |
0.16 |
chr9_123958262_123958421 | 13.96 |
Ccr1 |
chemokine (C-C motif) receptor 1 |
10351 |
0.17 |
chr4_70160648_70160837 | 13.91 |
Cdk5rap2 |
CDK5 regulatory subunit associated protein 2 |
83110 |
0.09 |
chr2_130248262_130248633 | 13.88 |
Nop56 |
NOP56 ribonucleoprotein |
25983 |
0.08 |
chr2_173038101_173038586 | 13.83 |
Gm14453 |
predicted gene 14453 |
3763 |
0.17 |
chr12_76670352_76670547 | 13.81 |
Sptb |
spectrin beta, erythrocytic |
39574 |
0.14 |
chr6_83395962_83396123 | 13.80 |
Mir6374 |
microRNA 6374 |
5060 |
0.13 |
chr5_32950813_32951166 | 13.77 |
Depdc5 |
DEP domain containing 5 |
6876 |
0.16 |
chr1_161895111_161895271 | 13.73 |
Gm31925 |
predicted gene, 31925 |
3044 |
0.21 |
chr1_136347174_136347468 | 13.73 |
Camsap2 |
calmodulin regulated spectrin-associated protein family, member 2 |
1217 |
0.44 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
15.8 | 47.4 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
15.1 | 90.7 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
13.2 | 13.2 | GO:0031047 | gene silencing by RNA(GO:0031047) |
11.1 | 33.3 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
10.3 | 41.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
10.1 | 10.1 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
10.1 | 30.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
9.9 | 29.7 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
9.1 | 27.4 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
8.7 | 34.9 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
8.6 | 25.8 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
8.6 | 34.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
8.3 | 24.9 | GO:0021553 | olfactory nerve development(GO:0021553) |
8.1 | 24.3 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
8.0 | 32.0 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
7.9 | 23.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
7.8 | 39.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
7.7 | 23.2 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
7.5 | 29.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
7.3 | 22.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
7.3 | 22.0 | GO:0000087 | mitotic M phase(GO:0000087) |
7.3 | 7.3 | GO:0046618 | drug export(GO:0046618) |
7.1 | 192.3 | GO:0048821 | erythrocyte development(GO:0048821) |
7.0 | 7.0 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
6.8 | 34.2 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
6.8 | 13.6 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
6.7 | 20.2 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
6.6 | 33.0 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
6.5 | 19.6 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
6.5 | 26.1 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
6.4 | 32.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
6.4 | 19.2 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
6.4 | 12.8 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
6.4 | 25.4 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
6.4 | 25.4 | GO:0070627 | ferrous iron import(GO:0070627) |
6.3 | 25.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
6.1 | 24.2 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
6.0 | 24.1 | GO:0008228 | opsonization(GO:0008228) |
6.0 | 18.0 | GO:0009196 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
6.0 | 41.8 | GO:0043173 | nucleotide salvage(GO:0043173) |
5.9 | 17.8 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
5.9 | 35.6 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
5.9 | 17.8 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
5.9 | 17.6 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
5.9 | 17.6 | GO:0018343 | protein farnesylation(GO:0018343) |
5.8 | 5.8 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
5.8 | 17.4 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
5.8 | 28.9 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
5.8 | 23.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
5.8 | 17.3 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
5.7 | 11.5 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
5.7 | 17.1 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
5.7 | 28.4 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
5.6 | 45.1 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
5.6 | 16.9 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
5.6 | 39.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
5.5 | 105.2 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
5.5 | 16.6 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
5.5 | 16.5 | GO:0002432 | granuloma formation(GO:0002432) |
5.5 | 21.9 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
5.4 | 27.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
5.4 | 32.5 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
5.4 | 10.8 | GO:0032782 | bile acid secretion(GO:0032782) |
5.4 | 5.4 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
5.4 | 10.7 | GO:0042908 | xenobiotic transport(GO:0042908) |
5.3 | 10.5 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
5.2 | 15.7 | GO:0018992 | germ-line sex determination(GO:0018992) |
5.2 | 15.6 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
5.1 | 10.3 | GO:0015684 | ferrous iron transport(GO:0015684) |
5.1 | 15.3 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
5.1 | 25.6 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
5.1 | 10.2 | GO:0045472 | response to ether(GO:0045472) |
5.0 | 20.0 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
5.0 | 15.0 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
5.0 | 19.9 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
4.9 | 9.7 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
4.9 | 19.5 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
4.9 | 24.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
4.8 | 14.4 | GO:0036394 | amylase secretion(GO:0036394) |
4.8 | 19.2 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
4.8 | 23.9 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
4.8 | 9.5 | GO:1901563 | response to camptothecin(GO:1901563) |
4.7 | 71.0 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
4.7 | 14.0 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
4.7 | 9.3 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
4.6 | 4.6 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
4.6 | 13.9 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
4.6 | 13.8 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
4.5 | 4.5 | GO:0006882 | cellular zinc ion homeostasis(GO:0006882) |
4.5 | 4.5 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
4.5 | 9.0 | GO:1901656 | glycoside transport(GO:1901656) |
4.5 | 13.4 | GO:0070827 | chromatin maintenance(GO:0070827) |
4.4 | 8.9 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
4.4 | 13.3 | GO:0042420 | dopamine catabolic process(GO:0042420) |
4.4 | 13.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
4.4 | 13.2 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
4.4 | 17.6 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
4.4 | 4.4 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
4.4 | 4.4 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
4.4 | 4.4 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
4.4 | 21.8 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
4.4 | 21.8 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
4.3 | 17.4 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
4.3 | 17.2 | GO:0043379 | memory T cell differentiation(GO:0043379) |
4.3 | 8.5 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
4.2 | 16.8 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
4.2 | 4.2 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
4.2 | 12.5 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
4.1 | 4.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
4.1 | 74.1 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
4.1 | 28.7 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
4.0 | 40.3 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
4.0 | 12.0 | GO:0008050 | female courtship behavior(GO:0008050) |
4.0 | 12.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
4.0 | 15.8 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
3.9 | 11.8 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
3.9 | 7.9 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
3.9 | 19.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
3.9 | 3.9 | GO:0048254 | snoRNA localization(GO:0048254) |
3.9 | 11.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
3.9 | 11.7 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
3.9 | 3.9 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
3.9 | 15.5 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
3.9 | 11.6 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
3.9 | 7.7 | GO:0006477 | protein sulfation(GO:0006477) |
3.9 | 15.4 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
3.8 | 15.4 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
3.8 | 15.3 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
3.8 | 15.3 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
3.8 | 11.4 | GO:0035973 | aggrephagy(GO:0035973) |
3.8 | 15.1 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
3.8 | 7.6 | GO:0043622 | cortical microtubule organization(GO:0043622) |
3.8 | 11.3 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
3.8 | 11.3 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
3.7 | 26.1 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
3.7 | 33.5 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
3.7 | 11.1 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
3.7 | 29.6 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
3.7 | 14.8 | GO:0071494 | cellular response to UV-C(GO:0071494) |
3.7 | 14.7 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
3.7 | 14.6 | GO:0006538 | glutamate catabolic process(GO:0006538) |
3.6 | 14.6 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
3.6 | 14.5 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
3.6 | 3.6 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
3.6 | 14.3 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
3.6 | 21.4 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
3.6 | 10.7 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
3.6 | 7.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
3.5 | 3.5 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
3.5 | 3.5 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
3.5 | 10.6 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
3.5 | 24.6 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
3.5 | 7.0 | GO:0072718 | response to cisplatin(GO:0072718) |
3.5 | 17.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
3.5 | 17.4 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
3.5 | 10.5 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
3.5 | 38.3 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
3.5 | 6.9 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
3.5 | 10.4 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
3.4 | 6.9 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
3.4 | 20.6 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
3.4 | 3.4 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
3.4 | 10.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
3.4 | 17.0 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
3.4 | 17.0 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
3.4 | 17.0 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
3.4 | 6.8 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
3.4 | 30.4 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
3.4 | 10.1 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
3.4 | 16.8 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
3.4 | 20.1 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
3.3 | 3.3 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
3.3 | 36.7 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
3.3 | 33.4 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
3.3 | 10.0 | GO:0070295 | renal water absorption(GO:0070295) |
3.3 | 3.3 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
3.3 | 10.0 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
3.3 | 9.9 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
3.3 | 16.5 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
3.3 | 9.9 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
3.3 | 23.0 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
3.3 | 3.3 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
3.3 | 3.3 | GO:0032898 | neurotrophin production(GO:0032898) |
3.3 | 19.6 | GO:0042168 | heme metabolic process(GO:0042168) |
3.3 | 13.1 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
3.3 | 16.3 | GO:0009642 | response to light intensity(GO:0009642) |
3.3 | 29.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
3.2 | 19.4 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
3.2 | 12.9 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
3.2 | 16.1 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
3.2 | 19.3 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
3.2 | 25.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
3.2 | 6.4 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
3.2 | 12.8 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
3.2 | 25.6 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
3.2 | 25.6 | GO:0030449 | regulation of complement activation(GO:0030449) |
3.2 | 47.9 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
3.2 | 3.2 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
3.2 | 19.1 | GO:0033572 | transferrin transport(GO:0033572) |
3.2 | 12.7 | GO:0009651 | response to salt stress(GO:0009651) |
3.2 | 15.9 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
3.2 | 25.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
3.2 | 3.2 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
3.2 | 15.8 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
3.1 | 25.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
3.1 | 22.0 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
3.1 | 9.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
3.1 | 18.8 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
3.1 | 6.2 | GO:0030242 | pexophagy(GO:0030242) |
3.1 | 6.2 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
3.1 | 9.3 | GO:0001555 | oocyte growth(GO:0001555) |
3.1 | 3.1 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
3.1 | 9.3 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
3.1 | 6.2 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
3.1 | 24.7 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
3.1 | 3.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
3.1 | 6.2 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
3.1 | 18.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
3.1 | 6.2 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
3.1 | 15.4 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
3.1 | 3.1 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
3.1 | 12.2 | GO:0051409 | response to nitrosative stress(GO:0051409) |
3.1 | 21.4 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
3.1 | 21.4 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
3.0 | 9.1 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
3.0 | 6.1 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
3.0 | 6.1 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
3.0 | 9.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
3.0 | 24.3 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
3.0 | 3.0 | GO:0046831 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
3.0 | 6.0 | GO:0035754 | B cell chemotaxis(GO:0035754) |
3.0 | 15.0 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
3.0 | 12.0 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
3.0 | 9.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
3.0 | 53.7 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
3.0 | 6.0 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
3.0 | 20.9 | GO:0045332 | phospholipid translocation(GO:0045332) |
3.0 | 8.9 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
3.0 | 14.8 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
3.0 | 17.7 | GO:0015871 | choline transport(GO:0015871) |
3.0 | 59.1 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
2.9 | 17.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
2.9 | 8.8 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
2.9 | 8.8 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
2.9 | 8.8 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
2.9 | 2.9 | GO:0097167 | circadian regulation of translation(GO:0097167) |
2.9 | 11.7 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
2.9 | 8.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
2.9 | 8.7 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
2.9 | 2.9 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
2.9 | 5.8 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
2.9 | 14.5 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
2.9 | 14.5 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
2.9 | 8.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
2.9 | 5.8 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
2.9 | 14.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
2.9 | 8.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
2.9 | 11.4 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
2.9 | 17.1 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
2.9 | 22.9 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
2.9 | 8.6 | GO:0048769 | sarcomerogenesis(GO:0048769) |
2.8 | 25.6 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
2.8 | 8.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
2.8 | 11.3 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
2.8 | 5.7 | GO:0030421 | defecation(GO:0030421) |
2.8 | 5.7 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
2.8 | 2.8 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
2.8 | 5.6 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
2.8 | 16.8 | GO:0016266 | O-glycan processing(GO:0016266) |
2.8 | 2.8 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
2.8 | 19.5 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
2.8 | 5.5 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
2.8 | 2.8 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
2.8 | 16.6 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
2.8 | 11.1 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
2.8 | 2.8 | GO:1902001 | plasma membrane long-chain fatty acid transport(GO:0015911) fatty acid transmembrane transport(GO:1902001) |
2.8 | 8.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
2.7 | 5.5 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
2.7 | 8.2 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
2.7 | 10.9 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
2.7 | 16.4 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
2.7 | 8.2 | GO:0042117 | monocyte activation(GO:0042117) |
2.7 | 2.7 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
2.7 | 8.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
2.7 | 19.1 | GO:0033194 | response to hydroperoxide(GO:0033194) |
2.7 | 8.2 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
2.7 | 13.6 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
2.7 | 27.1 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
2.7 | 2.7 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
2.7 | 5.4 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
2.7 | 35.0 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
2.7 | 8.0 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
2.7 | 2.7 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
2.7 | 10.7 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
2.7 | 5.3 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
2.7 | 15.9 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
2.7 | 15.9 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
2.7 | 5.3 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
2.6 | 15.9 | GO:0006561 | proline biosynthetic process(GO:0006561) |
2.6 | 5.3 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
2.6 | 13.2 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
2.6 | 5.3 | GO:2001252 | positive regulation of chromosome organization(GO:2001252) |
2.6 | 36.7 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
2.6 | 2.6 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
2.6 | 2.6 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
2.6 | 2.6 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
2.6 | 2.6 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
2.6 | 7.8 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
2.6 | 10.4 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
2.6 | 5.2 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
2.6 | 5.2 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
2.6 | 2.6 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
2.6 | 12.9 | GO:0021860 | pyramidal neuron development(GO:0021860) |
2.6 | 2.6 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
2.6 | 15.4 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
2.6 | 7.7 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
2.6 | 5.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
2.6 | 15.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
2.5 | 7.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
2.5 | 5.1 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) glandular epithelial cell maturation(GO:0002071) |
2.5 | 7.6 | GO:0019532 | oxalate transport(GO:0019532) |
2.5 | 12.7 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
2.5 | 15.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
2.5 | 2.5 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
2.5 | 17.7 | GO:0006012 | galactose metabolic process(GO:0006012) |
2.5 | 2.5 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
2.5 | 20.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
2.5 | 35.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
2.5 | 2.5 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
2.5 | 30.0 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
2.5 | 7.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
2.5 | 7.5 | GO:0007525 | somatic muscle development(GO:0007525) |
2.5 | 14.9 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
2.5 | 7.4 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
2.5 | 4.9 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
2.5 | 14.8 | GO:1901660 | calcium ion export(GO:1901660) |
2.5 | 17.3 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
2.5 | 9.9 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
2.5 | 12.3 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
2.5 | 12.3 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
2.5 | 12.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
2.5 | 7.4 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
2.4 | 4.9 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
2.4 | 9.7 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
2.4 | 17.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
2.4 | 14.6 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
2.4 | 14.5 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
2.4 | 4.8 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
2.4 | 4.8 | GO:0019081 | viral translation(GO:0019081) |
2.4 | 14.4 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
2.4 | 7.2 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
2.4 | 7.2 | GO:0006059 | hexitol metabolic process(GO:0006059) |
2.4 | 11.9 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
2.4 | 11.9 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
2.4 | 7.2 | GO:1904684 | regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
2.4 | 7.2 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
2.4 | 4.8 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
2.4 | 14.3 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
2.4 | 9.5 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
2.4 | 9.5 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
2.4 | 4.7 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
2.4 | 7.1 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
2.4 | 7.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
2.4 | 2.4 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
2.4 | 7.1 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
2.4 | 14.1 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
2.3 | 9.4 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
2.3 | 2.3 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
2.3 | 9.4 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
2.3 | 4.7 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
2.3 | 7.0 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
2.3 | 11.7 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
2.3 | 4.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
2.3 | 4.7 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
2.3 | 4.7 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
2.3 | 2.3 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
2.3 | 4.6 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
2.3 | 4.6 | GO:0034661 | ncRNA catabolic process(GO:0034661) |
2.3 | 6.9 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
2.3 | 66.8 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
2.3 | 2.3 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
2.3 | 2.3 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
2.3 | 4.6 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
2.3 | 9.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
2.3 | 6.9 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
2.3 | 4.5 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
2.3 | 13.6 | GO:0000237 | leptotene(GO:0000237) |
2.3 | 11.3 | GO:0080009 | mRNA methylation(GO:0080009) |
2.3 | 13.5 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
2.3 | 2.3 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
2.3 | 15.8 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
2.3 | 18.0 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
2.3 | 6.8 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
2.2 | 6.7 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
2.2 | 4.5 | GO:1902969 | mitotic DNA replication(GO:1902969) |
2.2 | 6.7 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
2.2 | 2.2 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
2.2 | 2.2 | GO:0032392 | DNA geometric change(GO:0032392) |
2.2 | 4.5 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
2.2 | 8.9 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
2.2 | 4.5 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
2.2 | 8.9 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
2.2 | 4.5 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
2.2 | 35.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
2.2 | 6.7 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
2.2 | 6.7 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
2.2 | 6.7 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
2.2 | 11.1 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
2.2 | 4.4 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
2.2 | 11.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
2.2 | 13.3 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
2.2 | 33.0 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
2.2 | 6.6 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
2.2 | 11.0 | GO:0051013 | microtubule severing(GO:0051013) |
2.2 | 2.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
2.2 | 2.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
2.2 | 4.4 | GO:2000978 | negative regulation of forebrain neuron differentiation(GO:2000978) |
2.2 | 4.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
2.2 | 6.5 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
2.2 | 10.9 | GO:0046040 | IMP metabolic process(GO:0046040) |
2.2 | 2.2 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
2.2 | 69.0 | GO:0006414 | translational elongation(GO:0006414) |
2.2 | 28.0 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
2.1 | 4.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
2.1 | 23.6 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
2.1 | 2.1 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
2.1 | 27.8 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
2.1 | 8.6 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
2.1 | 23.5 | GO:0051601 | exocyst localization(GO:0051601) |
2.1 | 2.1 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
2.1 | 2.1 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
2.1 | 6.4 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
2.1 | 32.0 | GO:0006308 | DNA catabolic process(GO:0006308) |
2.1 | 17.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
2.1 | 2.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
2.1 | 2.1 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
2.1 | 2.1 | GO:0048242 | epinephrine secretion(GO:0048242) |
2.1 | 6.4 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
2.1 | 8.5 | GO:0090527 | actin filament reorganization(GO:0090527) |
2.1 | 6.4 | GO:0019086 | late viral transcription(GO:0019086) |
2.1 | 4.2 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
2.1 | 12.7 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
2.1 | 6.3 | GO:1901525 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) negative regulation of mitophagy(GO:1903147) |
2.1 | 4.2 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
2.1 | 14.7 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
2.1 | 6.3 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
2.1 | 18.9 | GO:0017014 | protein nitrosylation(GO:0017014) |
2.1 | 10.5 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
2.1 | 6.3 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
2.1 | 6.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
2.1 | 2.1 | GO:0006475 | internal protein amino acid acetylation(GO:0006475) |
2.1 | 20.8 | GO:0051383 | kinetochore organization(GO:0051383) |
2.1 | 8.3 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
2.1 | 2.1 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
2.1 | 8.3 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
2.1 | 8.3 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
2.1 | 2.1 | GO:0016556 | mRNA modification(GO:0016556) |
2.1 | 2.1 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
2.1 | 10.4 | GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
2.1 | 4.1 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
2.1 | 14.5 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
2.1 | 8.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
2.0 | 4.1 | GO:0051029 | rRNA transport(GO:0051029) |
2.0 | 10.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
2.0 | 16.3 | GO:0006536 | glutamate metabolic process(GO:0006536) |
2.0 | 4.1 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
2.0 | 4.1 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
2.0 | 8.2 | GO:0010898 | regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
2.0 | 18.4 | GO:0031269 | pseudopodium assembly(GO:0031269) |
2.0 | 4.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
2.0 | 16.3 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
2.0 | 4.1 | GO:1904353 | regulation of telomere capping(GO:1904353) |
2.0 | 24.4 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
2.0 | 10.2 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
2.0 | 8.1 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
2.0 | 18.3 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
2.0 | 36.5 | GO:0000154 | rRNA modification(GO:0000154) |
2.0 | 8.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
2.0 | 8.1 | GO:0018904 | ether metabolic process(GO:0018904) |
2.0 | 10.1 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
2.0 | 4.0 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
2.0 | 34.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
2.0 | 2.0 | GO:0099515 | actin filament-based transport(GO:0099515) |
2.0 | 10.0 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
2.0 | 4.0 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
2.0 | 27.8 | GO:0072520 | seminiferous tubule development(GO:0072520) |
2.0 | 15.8 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
2.0 | 5.9 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
2.0 | 37.5 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
2.0 | 43.4 | GO:0046460 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
2.0 | 7.9 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
2.0 | 7.9 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
2.0 | 5.9 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
2.0 | 5.9 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
2.0 | 84.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
1.9 | 3.9 | GO:0015886 | heme transport(GO:0015886) |
1.9 | 7.6 | GO:0036010 | protein localization to endosome(GO:0036010) |
1.9 | 20.9 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
1.9 | 24.7 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
1.9 | 36.1 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
1.9 | 15.2 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
1.9 | 1.9 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
1.9 | 1.9 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
1.9 | 17.0 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
1.9 | 1.9 | GO:1902065 | response to L-glutamate(GO:1902065) |
1.9 | 1.9 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
1.9 | 7.6 | GO:0016139 | glycoside catabolic process(GO:0016139) |
1.9 | 18.9 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
1.9 | 18.8 | GO:0001675 | acrosome assembly(GO:0001675) |
1.9 | 11.3 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
1.9 | 3.7 | GO:0034770 | histone H4-K20 methylation(GO:0034770) histone H4-K20 trimethylation(GO:0034773) |
1.9 | 3.7 | GO:0001692 | histamine metabolic process(GO:0001692) |
1.9 | 11.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
1.9 | 7.5 | GO:0015705 | iodide transport(GO:0015705) |
1.9 | 9.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
1.9 | 11.2 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
1.9 | 5.6 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
1.9 | 1.9 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
1.9 | 7.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
1.9 | 22.3 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
1.9 | 3.7 | GO:0051036 | regulation of endosome size(GO:0051036) |
1.9 | 5.6 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.9 | 5.6 | GO:2001225 | regulation of chloride transport(GO:2001225) |
1.9 | 3.7 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
1.8 | 9.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
1.8 | 24.0 | GO:0032801 | receptor catabolic process(GO:0032801) |
1.8 | 7.4 | GO:0070914 | UV-damage excision repair(GO:0070914) |
1.8 | 3.7 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
1.8 | 1.8 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
1.8 | 5.5 | GO:0002254 | kinin cascade(GO:0002254) |
1.8 | 64.4 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
1.8 | 9.2 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
1.8 | 14.6 | GO:0007343 | egg activation(GO:0007343) |
1.8 | 9.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
1.8 | 25.4 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
1.8 | 10.9 | GO:0006013 | mannose metabolic process(GO:0006013) |
1.8 | 3.6 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
1.8 | 3.6 | GO:0061511 | centriole elongation(GO:0061511) |
1.8 | 5.4 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
1.8 | 1.8 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
1.8 | 16.3 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
1.8 | 10.8 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
1.8 | 18.0 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
1.8 | 7.2 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
1.8 | 3.6 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
1.8 | 12.5 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
1.8 | 25.0 | GO:0030488 | tRNA methylation(GO:0030488) |
1.8 | 5.4 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
1.8 | 17.9 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
1.8 | 1.8 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.8 | 10.7 | GO:0046686 | response to cadmium ion(GO:0046686) |
1.8 | 3.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
1.8 | 3.6 | GO:0007035 | vacuolar acidification(GO:0007035) |
1.8 | 1.8 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
1.8 | 8.9 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
1.8 | 1.8 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
1.8 | 19.5 | GO:0045116 | protein neddylation(GO:0045116) |
1.8 | 5.3 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
1.8 | 5.3 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
1.8 | 7.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
1.8 | 15.9 | GO:0070269 | pyroptosis(GO:0070269) |
1.8 | 24.6 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
1.8 | 7.0 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
1.8 | 7.0 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
1.7 | 1.7 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
1.7 | 31.3 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
1.7 | 60.8 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
1.7 | 8.7 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
1.7 | 13.9 | GO:0035493 | SNARE complex assembly(GO:0035493) |
1.7 | 5.2 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
1.7 | 6.9 | GO:0051031 | tRNA transport(GO:0051031) |
1.7 | 10.4 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
1.7 | 6.9 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
1.7 | 6.9 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
1.7 | 1.7 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
1.7 | 6.9 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
1.7 | 22.4 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
1.7 | 5.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
1.7 | 10.3 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
1.7 | 15.4 | GO:0006625 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
1.7 | 3.4 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
1.7 | 3.4 | GO:1903660 | complement-dependent cytotoxicity(GO:0097278) regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
1.7 | 3.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.7 | 1.7 | GO:0021747 | cochlear nucleus development(GO:0021747) |
1.7 | 6.8 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
1.7 | 10.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
1.7 | 5.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
1.7 | 8.5 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
1.7 | 5.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
1.7 | 11.8 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
1.7 | 18.6 | GO:0006903 | vesicle targeting(GO:0006903) |
1.7 | 38.9 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
1.7 | 3.4 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
1.7 | 5.0 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
1.7 | 1.7 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
1.7 | 6.7 | GO:0035627 | ceramide transport(GO:0035627) |
1.7 | 5.0 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.7 | 5.0 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
1.7 | 3.3 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
1.7 | 46.5 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
1.7 | 11.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
1.7 | 3.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
1.7 | 1.7 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
1.7 | 3.3 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.7 | 5.0 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
1.7 | 8.3 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
1.7 | 5.0 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.6 | 24.7 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
1.6 | 1.6 | GO:0060920 | cardiac pacemaker cell differentiation(GO:0060920) |
1.6 | 19.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
1.6 | 3.3 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
1.6 | 55.7 | GO:0006611 | protein export from nucleus(GO:0006611) |
1.6 | 6.5 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
1.6 | 8.2 | GO:0007097 | nuclear migration(GO:0007097) |
1.6 | 3.3 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
1.6 | 4.9 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
1.6 | 4.9 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
1.6 | 8.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
1.6 | 8.2 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
1.6 | 3.3 | GO:0043558 | regulation of translational initiation in response to stress(GO:0043558) |
1.6 | 6.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
1.6 | 16.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
1.6 | 11.4 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
1.6 | 13.0 | GO:0042448 | progesterone metabolic process(GO:0042448) |
1.6 | 6.5 | GO:0034063 | stress granule assembly(GO:0034063) |
1.6 | 9.7 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
1.6 | 3.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
1.6 | 3.2 | GO:0030576 | Cajal body organization(GO:0030576) |
1.6 | 4.8 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
1.6 | 4.8 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
1.6 | 3.2 | GO:0002215 | defense response to nematode(GO:0002215) |
1.6 | 14.5 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
1.6 | 3.2 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
1.6 | 8.0 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
1.6 | 4.8 | GO:0060789 | hair follicle placode formation(GO:0060789) |
1.6 | 11.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
1.6 | 16.0 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
1.6 | 27.1 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
1.6 | 6.4 | GO:0015858 | nucleoside transport(GO:0015858) |
1.6 | 11.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
1.6 | 79.7 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
1.6 | 3.2 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
1.6 | 47.8 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
1.6 | 38.2 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
1.6 | 25.4 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
1.6 | 12.7 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
1.6 | 9.5 | GO:0045047 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
1.6 | 7.9 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
1.6 | 3.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
1.6 | 3.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
1.6 | 6.3 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
1.6 | 3.1 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
1.6 | 1.6 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
1.6 | 1.6 | GO:1903551 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
1.6 | 6.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
1.6 | 3.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
1.6 | 1.6 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
1.6 | 3.1 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
1.5 | 12.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
1.5 | 7.7 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
1.5 | 29.1 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
1.5 | 1.5 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
1.5 | 1.5 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
1.5 | 57.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
1.5 | 1.5 | GO:0019530 | taurine metabolic process(GO:0019530) |
1.5 | 1.5 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
1.5 | 1.5 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
1.5 | 3.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
1.5 | 9.1 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
1.5 | 42.3 | GO:0006953 | acute-phase response(GO:0006953) |
1.5 | 4.5 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
1.5 | 3.0 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
1.5 | 10.5 | GO:0042730 | fibrinolysis(GO:0042730) |
1.5 | 1.5 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
1.5 | 4.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
1.5 | 4.5 | GO:0006116 | NADH oxidation(GO:0006116) |
1.5 | 1.5 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
1.5 | 59.6 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
1.5 | 8.9 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
1.5 | 17.8 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
1.5 | 3.0 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
1.5 | 4.4 | GO:0009838 | abscission(GO:0009838) |
1.5 | 4.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
1.5 | 14.8 | GO:0009147 | pyrimidine nucleoside triphosphate metabolic process(GO:0009147) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) |
1.5 | 5.9 | GO:0003091 | renal water homeostasis(GO:0003091) |
1.5 | 7.4 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
1.5 | 8.8 | GO:0071318 | cellular response to ATP(GO:0071318) |
1.5 | 4.4 | GO:0009826 | unidimensional cell growth(GO:0009826) |
1.5 | 2.9 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
1.5 | 2.9 | GO:0016572 | histone phosphorylation(GO:0016572) |
1.5 | 2.9 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
1.5 | 8.8 | GO:2000758 | positive regulation of peptidyl-lysine acetylation(GO:2000758) |
1.5 | 1.5 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
1.5 | 5.8 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
1.5 | 7.3 | GO:0015671 | oxygen transport(GO:0015671) |
1.5 | 4.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
1.4 | 17.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
1.4 | 4.3 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
1.4 | 1.4 | GO:0070199 | establishment of protein localization to chromosome(GO:0070199) establishment of protein localization to chromatin(GO:0071169) |
1.4 | 4.3 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
1.4 | 14.4 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
1.4 | 5.7 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
1.4 | 1.4 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
1.4 | 4.3 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
1.4 | 5.7 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
1.4 | 5.7 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
1.4 | 12.8 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
1.4 | 5.7 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
1.4 | 1.4 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
1.4 | 7.1 | GO:0051026 | chiasma assembly(GO:0051026) |
1.4 | 4.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
1.4 | 16.9 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
1.4 | 1.4 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
1.4 | 4.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
1.4 | 5.6 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
1.4 | 5.6 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
1.4 | 46.0 | GO:0043966 | histone H3 acetylation(GO:0043966) |
1.4 | 5.6 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
1.4 | 8.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
1.4 | 54.1 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
1.4 | 9.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
1.4 | 4.2 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
1.4 | 4.2 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
1.4 | 1.4 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
1.4 | 2.8 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
1.4 | 4.1 | GO:1902804 | negative regulation of synaptic vesicle transport(GO:1902804) |
1.4 | 5.5 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
1.4 | 1.4 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
1.4 | 2.8 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.4 | 4.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.4 | 1.4 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
1.4 | 2.7 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
1.4 | 1.4 | GO:0046689 | response to mercury ion(GO:0046689) |
1.4 | 1.4 | GO:0070488 | neutrophil aggregation(GO:0070488) |
1.4 | 2.7 | GO:0051541 | elastin metabolic process(GO:0051541) |
1.4 | 1.4 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.4 | 4.1 | GO:0031498 | chromatin disassembly(GO:0031498) |
1.4 | 5.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
1.4 | 8.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
1.4 | 4.1 | GO:0015825 | L-serine transport(GO:0015825) |
1.4 | 1.4 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
1.4 | 2.7 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
1.4 | 2.7 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
1.4 | 4.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
1.4 | 2.7 | GO:0006401 | RNA catabolic process(GO:0006401) |
1.3 | 5.4 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
1.3 | 6.7 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
1.3 | 13.5 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
1.3 | 9.4 | GO:0015865 | purine nucleotide transport(GO:0015865) |
1.3 | 16.1 | GO:0051168 | nuclear export(GO:0051168) |
1.3 | 1.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
1.3 | 14.8 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
1.3 | 1.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
1.3 | 8.0 | GO:0046415 | urate metabolic process(GO:0046415) |
1.3 | 1.3 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
1.3 | 4.0 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
1.3 | 1.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
1.3 | 5.3 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
1.3 | 1.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.3 | 4.0 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
1.3 | 4.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
1.3 | 4.0 | GO:0044359 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
1.3 | 2.6 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.3 | 19.7 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
1.3 | 3.9 | GO:0046039 | GTP metabolic process(GO:0046039) |
1.3 | 2.6 | GO:0071025 | RNA surveillance(GO:0071025) |
1.3 | 5.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.3 | 3.9 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
1.3 | 3.9 | GO:0008089 | anterograde axonal transport(GO:0008089) |
1.3 | 5.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
1.3 | 45.4 | GO:0051225 | spindle assembly(GO:0051225) |
1.3 | 9.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
1.3 | 18.1 | GO:0006829 | zinc II ion transport(GO:0006829) |
1.3 | 3.9 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
1.3 | 16.8 | GO:0016180 | snRNA processing(GO:0016180) |
1.3 | 3.9 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
1.3 | 2.6 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.3 | 2.6 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) dermatan sulfate proteoglycan metabolic process(GO:0050655) |
1.3 | 3.8 | GO:0060988 | lipid tube assembly(GO:0060988) |
1.3 | 14.1 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
1.3 | 7.6 | GO:0050779 | RNA destabilization(GO:0050779) |
1.3 | 16.5 | GO:0007099 | centriole replication(GO:0007099) |
1.3 | 2.5 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
1.3 | 2.5 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
1.3 | 16.5 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
1.3 | 67.2 | GO:0008033 | tRNA processing(GO:0008033) |
1.3 | 1.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
1.3 | 1.3 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
1.3 | 1.3 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
1.3 | 5.0 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
1.3 | 8.8 | GO:0060539 | diaphragm development(GO:0060539) |
1.3 | 2.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
1.3 | 11.3 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
1.3 | 7.5 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
1.3 | 5.0 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
1.3 | 1.3 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
1.2 | 3.7 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
1.2 | 3.7 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
1.2 | 5.0 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
1.2 | 2.5 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
1.2 | 2.5 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
1.2 | 22.3 | GO:0006749 | glutathione metabolic process(GO:0006749) |
1.2 | 2.5 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
1.2 | 1.2 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
1.2 | 2.5 | GO:0030578 | PML body organization(GO:0030578) |
1.2 | 11.0 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
1.2 | 1.2 | GO:0070671 | response to interleukin-12(GO:0070671) |
1.2 | 2.4 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
1.2 | 8.5 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
1.2 | 4.9 | GO:1902622 | regulation of neutrophil migration(GO:1902622) |
1.2 | 14.5 | GO:0006491 | N-glycan processing(GO:0006491) |
1.2 | 2.4 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
1.2 | 3.6 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
1.2 | 1.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
1.2 | 3.6 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
1.2 | 3.6 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
1.2 | 1.2 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
1.2 | 6.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
1.2 | 30.9 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
1.2 | 2.4 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
1.2 | 2.4 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.2 | 3.6 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.2 | 2.4 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
1.2 | 1.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
1.2 | 2.4 | GO:0061010 | gall bladder development(GO:0061010) |
1.2 | 29.5 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
1.2 | 5.9 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
1.2 | 5.9 | GO:0006415 | translational termination(GO:0006415) |
1.2 | 23.4 | GO:0000266 | mitochondrial fission(GO:0000266) |
1.2 | 2.3 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
1.2 | 1.2 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
1.2 | 4.7 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
1.2 | 2.3 | GO:0048102 | autophagic cell death(GO:0048102) |
1.2 | 1.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
1.2 | 5.8 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
1.2 | 3.5 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
1.2 | 2.3 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
1.2 | 1.2 | GO:2000650 | negative regulation of sodium ion transmembrane transport(GO:1902306) negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
1.2 | 1.2 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
1.2 | 2.3 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
1.2 | 6.9 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
1.1 | 16.1 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
1.1 | 2.3 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
1.1 | 2.3 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
1.1 | 11.4 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
1.1 | 4.6 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
1.1 | 1.1 | GO:0032329 | serine transport(GO:0032329) |
1.1 | 5.7 | GO:0034508 | centromere complex assembly(GO:0034508) |
1.1 | 1.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
1.1 | 3.4 | GO:0060337 | type I interferon signaling pathway(GO:0060337) |
1.1 | 4.5 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
1.1 | 15.8 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
1.1 | 3.4 | GO:1903748 | negative regulation of protein targeting to mitochondrion(GO:1903215) negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
1.1 | 25.9 | GO:0016575 | histone deacetylation(GO:0016575) |
1.1 | 2.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
1.1 | 10.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
1.1 | 4.5 | GO:0015074 | DNA integration(GO:0015074) |
1.1 | 3.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.1 | 10.0 | GO:0006020 | inositol metabolic process(GO:0006020) |
1.1 | 8.9 | GO:0008343 | adult feeding behavior(GO:0008343) |
1.1 | 5.6 | GO:0016071 | mRNA metabolic process(GO:0016071) |
1.1 | 3.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.1 | 3.3 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
1.1 | 9.9 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
1.1 | 2.2 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
1.1 | 1.1 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
1.1 | 3.3 | GO:0035372 | protein localization to microtubule(GO:0035372) |
1.1 | 1.1 | GO:0070828 | heterochromatin organization(GO:0070828) |
1.1 | 14.2 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
1.1 | 4.4 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.1 | 2.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
1.1 | 3.3 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
1.1 | 1.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
1.1 | 1.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
1.1 | 1.1 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
1.1 | 8.7 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
1.1 | 1.1 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
1.1 | 6.5 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
1.1 | 2.2 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
1.1 | 1.1 | GO:0060969 | negative regulation of gene silencing(GO:0060969) |
1.1 | 4.3 | GO:0006301 | postreplication repair(GO:0006301) |
1.1 | 5.4 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
1.1 | 11.8 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
1.1 | 8.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
1.1 | 1.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
1.1 | 3.2 | GO:0035608 | protein deglutamylation(GO:0035608) |
1.1 | 1.1 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
1.1 | 2.1 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
1.1 | 27.7 | GO:0015804 | neutral amino acid transport(GO:0015804) |
1.1 | 7.5 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
1.1 | 4.2 | GO:0006817 | phosphate ion transport(GO:0006817) |
1.1 | 6.4 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
1.1 | 8.5 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
1.1 | 4.2 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
1.1 | 23.3 | GO:0000077 | DNA damage checkpoint(GO:0000077) |
1.1 | 3.2 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
1.1 | 3.2 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
1.0 | 9.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
1.0 | 4.2 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
1.0 | 8.4 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
1.0 | 3.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
1.0 | 10.4 | GO:0002115 | store-operated calcium entry(GO:0002115) |
1.0 | 6.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
1.0 | 48.7 | GO:0051028 | mRNA transport(GO:0051028) |
1.0 | 2.1 | GO:0042891 | antibiotic transport(GO:0042891) |
1.0 | 2.1 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
1.0 | 2.1 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
1.0 | 4.1 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
1.0 | 4.1 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
1.0 | 2.1 | GO:0097066 | response to thyroid hormone(GO:0097066) |
1.0 | 2.0 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
1.0 | 2.0 | GO:0009435 | NAD biosynthetic process(GO:0009435) nicotinamide nucleotide biosynthetic process(GO:0019359) |
1.0 | 4.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
1.0 | 4.1 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
1.0 | 20.3 | GO:0002181 | cytoplasmic translation(GO:0002181) |
1.0 | 1.0 | GO:0032202 | telomere assembly(GO:0032202) |
1.0 | 2.0 | GO:0044786 | cell cycle DNA replication(GO:0044786) |
1.0 | 2.0 | GO:2001138 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
1.0 | 1.0 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
1.0 | 3.0 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
1.0 | 9.0 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
1.0 | 3.0 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
1.0 | 3.0 | GO:0015744 | succinate transport(GO:0015744) |
1.0 | 16.8 | GO:0071472 | cellular response to salt stress(GO:0071472) |
1.0 | 3.9 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
1.0 | 1.0 | GO:0016577 | histone demethylation(GO:0016577) |
1.0 | 9.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
1.0 | 2.9 | GO:0006513 | protein monoubiquitination(GO:0006513) |
1.0 | 1.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
1.0 | 31.2 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
1.0 | 7.8 | GO:0046549 | retinal cone cell development(GO:0046549) |
1.0 | 3.9 | GO:0071826 | ribonucleoprotein complex subunit organization(GO:0071826) |
1.0 | 1.9 | GO:0060591 | chondroblast differentiation(GO:0060591) |
1.0 | 1.0 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
1.0 | 4.8 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) |
1.0 | 1.0 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
1.0 | 4.8 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
1.0 | 1.9 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
1.0 | 2.9 | GO:0046909 | intermembrane transport(GO:0046909) |
1.0 | 2.9 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.9 | 0.9 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.9 | 11.4 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.9 | 0.9 | GO:0050955 | thermoception(GO:0050955) |
0.9 | 19.8 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.9 | 0.9 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.9 | 3.7 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.9 | 1.9 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.9 | 0.9 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.9 | 1.9 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.9 | 2.8 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.9 | 1.9 | GO:2000348 | CD40 signaling pathway(GO:0023035) regulation of CD40 signaling pathway(GO:2000348) |
0.9 | 1.8 | GO:0043039 | amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
0.9 | 24.7 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.9 | 2.7 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.9 | 2.7 | GO:0016570 | histone modification(GO:0016570) |
0.9 | 0.9 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.9 | 6.3 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.9 | 1.8 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.9 | 3.6 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.9 | 4.5 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.9 | 1.8 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.9 | 1.8 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.9 | 7.2 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
0.9 | 6.3 | GO:0002934 | desmosome organization(GO:0002934) |
0.9 | 1.8 | GO:1902075 | cellular response to salt(GO:1902075) |
0.9 | 0.9 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.9 | 5.3 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.9 | 1.8 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.9 | 0.9 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.9 | 0.9 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.9 | 7.0 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.9 | 0.9 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.9 | 4.4 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.9 | 0.9 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.9 | 2.6 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.9 | 1.7 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.9 | 2.6 | GO:0006057 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.9 | 2.6 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.9 | 0.9 | GO:0009299 | mRNA transcription(GO:0009299) |
0.9 | 0.9 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.9 | 1.7 | GO:1990874 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
0.9 | 0.9 | GO:0006304 | DNA modification(GO:0006304) |
0.9 | 40.2 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.9 | 0.9 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.9 | 4.3 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.9 | 1.7 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.8 | 0.8 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.8 | 1.7 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.8 | 1.7 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.8 | 2.5 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.8 | 20.3 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.8 | 3.4 | GO:0009249 | protein lipoylation(GO:0009249) |
0.8 | 2.5 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.8 | 1.7 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.8 | 0.8 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.8 | 1.7 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.8 | 9.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.8 | 10.9 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.8 | 9.2 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.8 | 0.8 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.8 | 16.7 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.8 | 10.0 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.8 | 0.8 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.8 | 8.3 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.8 | 0.8 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.8 | 4.1 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.8 | 0.8 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.8 | 3.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.8 | 0.8 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.8 | 0.8 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.8 | 0.8 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.8 | 1.6 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.8 | 0.8 | GO:0006837 | serotonin transport(GO:0006837) |
0.8 | 9.9 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.8 | 6.6 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.8 | 15.5 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.8 | 4.9 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.8 | 4.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.8 | 4.1 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.8 | 3.3 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.8 | 2.4 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.8 | 0.8 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) |
0.8 | 2.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.8 | 2.4 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.8 | 24.3 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.8 | 15.4 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.8 | 1.6 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.8 | 4.0 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.8 | 8.1 | GO:0032648 | interferon-beta production(GO:0032608) regulation of interferon-beta production(GO:0032648) |
0.8 | 0.8 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.8 | 1.6 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.8 | 12.9 | GO:0031023 | microtubule organizing center organization(GO:0031023) |
0.8 | 2.4 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.8 | 1.6 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.8 | 2.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.8 | 1.6 | GO:0033762 | response to glucagon(GO:0033762) |
0.8 | 1.6 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.8 | 0.8 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.8 | 4.7 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.8 | 63.1 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.8 | 1.6 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.8 | 1.6 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.8 | 9.4 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.8 | 2.4 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.8 | 3.1 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.8 | 0.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.8 | 7.8 | GO:0072676 | lymphocyte migration(GO:0072676) |
0.8 | 2.3 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
0.8 | 0.8 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.8 | 17.9 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.8 | 0.8 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.8 | 4.7 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.8 | 10.1 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.8 | 3.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.8 | 11.6 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.8 | 6.9 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.8 | 1.5 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.8 | 3.8 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.8 | 3.8 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.8 | 2.3 | GO:0010039 | response to iron ion(GO:0010039) |
0.8 | 6.1 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.8 | 1.5 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
0.8 | 2.3 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.8 | 1.5 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.8 | 0.8 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.7 | 1.5 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.7 | 1.5 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.7 | 3.0 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.7 | 7.5 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.7 | 13.4 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.7 | 0.7 | GO:2000676 | regulation of type B pancreatic cell apoptotic process(GO:2000674) positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.7 | 1.5 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.7 | 3.7 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.7 | 3.7 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.7 | 1.5 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.7 | 1.5 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.7 | 4.4 | GO:0006968 | cellular defense response(GO:0006968) |
0.7 | 2.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.7 | 0.7 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.7 | 0.7 | GO:0009750 | response to fructose(GO:0009750) |
0.7 | 5.8 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.7 | 4.3 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.7 | 7.9 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.7 | 2.9 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.7 | 4.3 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.7 | 0.7 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
0.7 | 2.9 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.7 | 14.2 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.7 | 23.5 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.7 | 9.9 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.7 | 9.2 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
0.7 | 2.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.7 | 91.6 | GO:0008380 | RNA splicing(GO:0008380) |
0.7 | 0.7 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.7 | 2.1 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.7 | 1.4 | GO:0048302 | isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) |
0.7 | 11.7 | GO:0031929 | TOR signaling(GO:0031929) |
0.7 | 24.8 | GO:0006397 | mRNA processing(GO:0006397) |
0.7 | 5.5 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.7 | 0.7 | GO:1903543 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
0.7 | 2.0 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.7 | 1.4 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.7 | 4.1 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.7 | 0.7 | GO:0001796 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.7 | 1.3 | GO:0001302 | replicative cell aging(GO:0001302) |
0.7 | 2.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.7 | 5.3 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.7 | 2.6 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.7 | 25.7 | GO:0016568 | chromatin modification(GO:0016568) |
0.7 | 0.7 | GO:0052040 | negative regulation by symbiont of host apoptotic process(GO:0033668) modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) negative regulation by symbiont of host programmed cell death(GO:0052041) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.7 | 2.0 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.7 | 5.3 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.7 | 1.3 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.7 | 5.9 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.7 | 1.3 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.6 | 0.6 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.6 | 4.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.6 | 1.9 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.6 | 2.6 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.6 | 2.6 | GO:0007031 | peroxisome organization(GO:0007031) |
0.6 | 1.9 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.6 | 1.9 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.6 | 2.5 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.6 | 0.6 | GO:0002477 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
0.6 | 14.6 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
0.6 | 0.6 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.6 | 2.5 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.6 | 0.6 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.6 | 1.9 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.6 | 1.2 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.6 | 3.7 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.6 | 7.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.6 | 2.5 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.6 | 1.9 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.6 | 4.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.6 | 2.5 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.6 | 4.3 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.6 | 2.4 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.6 | 3.0 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.6 | 1.2 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.6 | 0.6 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.6 | 4.9 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.6 | 3.0 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.6 | 1.2 | GO:0007127 | meiosis I(GO:0007127) |
0.6 | 20.5 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
0.6 | 1.2 | GO:0070266 | necroptotic process(GO:0070266) |
0.6 | 0.6 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.6 | 3.0 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.6 | 0.6 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.6 | 3.0 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.6 | 1.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.6 | 1.2 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.6 | 6.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.6 | 2.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.6 | 2.9 | GO:1904970 | brush border assembly(GO:1904970) |
0.6 | 1.8 | GO:0044110 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
0.6 | 1.8 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.6 | 1.2 | GO:0070254 | mucus secretion(GO:0070254) |
0.6 | 1.2 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.6 | 3.5 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.6 | 0.6 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.6 | 2.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.6 | 0.6 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.6 | 9.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.6 | 0.6 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.6 | 3.9 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.6 | 26.7 | GO:0006457 | protein folding(GO:0006457) |
0.6 | 8.3 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.6 | 2.2 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.6 | 8.3 | GO:0019835 | cytolysis(GO:0019835) |
0.6 | 0.6 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.5 | 1.6 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.5 | 0.5 | GO:0051182 | coenzyme transport(GO:0051182) |
0.5 | 0.5 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.5 | 2.2 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.5 | 2.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.5 | 3.8 | GO:0042407 | cristae formation(GO:0042407) |
0.5 | 6.5 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.5 | 0.5 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
0.5 | 1.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.5 | 2.7 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.5 | 0.5 | GO:0097531 | mast cell migration(GO:0097531) |
0.5 | 1.6 | GO:0045931 | positive regulation of mitotic cell cycle(GO:0045931) |
0.5 | 1.6 | GO:0015888 | thiamine transport(GO:0015888) |
0.5 | 0.5 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.5 | 0.5 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.5 | 4.8 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.5 | 2.1 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
0.5 | 2.1 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.5 | 4.8 | GO:0061097 | regulation of protein tyrosine kinase activity(GO:0061097) |
0.5 | 1.1 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.5 | 0.5 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.5 | 0.5 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
0.5 | 2.6 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.5 | 0.5 | GO:0006983 | ER overload response(GO:0006983) |
0.5 | 0.5 | GO:0046016 | positive regulation of transcription by glucose(GO:0046016) |
0.5 | 0.5 | GO:0098732 | protein deacylation(GO:0035601) macromolecule deacylation(GO:0098732) |
0.5 | 3.6 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.5 | 1.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.5 | 0.5 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.5 | 6.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.5 | 8.1 | GO:0010608 | posttranscriptional regulation of gene expression(GO:0010608) |
0.5 | 6.6 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.5 | 0.5 | GO:1901985 | positive regulation of protein acetylation(GO:1901985) |
0.5 | 2.0 | GO:0006956 | complement activation(GO:0006956) |
0.5 | 4.0 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.5 | 2.0 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.5 | 1.0 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.5 | 0.5 | GO:1990182 | exosomal secretion(GO:1990182) |
0.5 | 0.5 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.5 | 2.9 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.5 | 1.0 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.5 | 3.9 | GO:0001562 | response to protozoan(GO:0001562) |
0.5 | 2.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.5 | 0.5 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.5 | 1.5 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.5 | 0.5 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.5 | 0.5 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.5 | 7.3 | GO:0018394 | peptidyl-lysine acetylation(GO:0018394) |
0.5 | 1.9 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.5 | 0.5 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.5 | 1.4 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.5 | 4.3 | GO:0050832 | defense response to fungus(GO:0050832) |
0.5 | 1.9 | GO:0097502 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) protein mannosylation(GO:0035268) mannosylation(GO:0097502) |
0.5 | 3.3 | GO:0000338 | protein deneddylation(GO:0000338) |
0.5 | 0.9 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.5 | 0.5 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.5 | 0.5 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.5 | 0.5 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.5 | 1.4 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.5 | 2.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.5 | 0.9 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.5 | 0.5 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.5 | 14.6 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.5 | 9.1 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.5 | 2.3 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.5 | 3.6 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.5 | 4.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.5 | 33.8 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.4 | 0.9 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.4 | 1.3 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.4 | 3.6 | GO:0006284 | base-excision repair(GO:0006284) |
0.4 | 19.6 | GO:0007059 | chromosome segregation(GO:0007059) |
0.4 | 0.4 | GO:0070417 | cellular response to cold(GO:0070417) |
0.4 | 0.4 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.4 | 0.9 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.4 | 5.2 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.4 | 1.3 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.4 | 0.4 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) |
0.4 | 0.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.4 | 0.4 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.4 | 0.4 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.4 | 3.4 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.4 | 0.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.4 | 0.9 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.4 | 1.3 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.4 | 7.7 | GO:0006396 | RNA processing(GO:0006396) |
0.4 | 1.3 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.4 | 0.4 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) negative regulation of mitochondrial fusion(GO:0010637) |
0.4 | 1.7 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.4 | 3.7 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.4 | 4.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.4 | 0.8 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.4 | 0.4 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.4 | 0.4 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.4 | 2.4 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.4 | 0.8 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.4 | 4.8 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.4 | 1.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.4 | 5.8 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.4 | 1.6 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.4 | 3.5 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.4 | 0.8 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.4 | 19.0 | GO:0006281 | DNA repair(GO:0006281) |
0.4 | 1.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.4 | 0.8 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.4 | 1.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.4 | 2.6 | GO:0045576 | mast cell activation(GO:0045576) |
0.4 | 0.8 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.4 | 1.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.4 | 3.0 | GO:0010324 | membrane invagination(GO:0010324) |
0.4 | 1.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.4 | 0.4 | GO:0009264 | deoxyribonucleotide catabolic process(GO:0009264) deoxyribonucleoside catabolic process(GO:0046121) |
0.4 | 1.1 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.4 | 1.1 | GO:0032095 | regulation of response to food(GO:0032095) |
0.4 | 0.4 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.4 | 0.7 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.4 | 0.7 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.4 | 1.8 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.4 | 2.2 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.4 | 1.1 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.4 | 5.8 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.4 | 0.7 | GO:0051187 | cofactor catabolic process(GO:0051187) |
0.4 | 0.7 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.4 | 1.1 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.4 | 3.5 | GO:0046916 | cellular transition metal ion homeostasis(GO:0046916) |
0.4 | 2.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.4 | 0.4 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.4 | 2.5 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.3 | 7.7 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.3 | 0.3 | GO:0046137 | negative regulation of vitamin metabolic process(GO:0046137) |
0.3 | 0.3 | GO:0051340 | regulation of ligase activity(GO:0051340) |
0.3 | 1.4 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.3 | 0.7 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.3 | 0.3 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.3 | 0.7 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.3 | 3.4 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.3 | 2.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.3 | 0.3 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.3 | 1.3 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.3 | 0.3 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.3 | 0.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.3 | 1.3 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.3 | 1.0 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.3 | 0.9 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.3 | 0.9 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.3 | 4.7 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.3 | 0.3 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.3 | 2.2 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.3 | 0.3 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.3 | 0.3 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.3 | 0.9 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) regulation of respiratory system process(GO:0044065) |
0.3 | 0.9 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.3 | 0.6 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.3 | 0.6 | GO:0007567 | parturition(GO:0007567) |
0.3 | 0.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.3 | 0.6 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.3 | 0.3 | GO:0003096 | renal sodium ion transport(GO:0003096) |
0.3 | 8.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.3 | 0.6 | GO:0003011 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.3 | 0.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.3 | 0.6 | GO:0051883 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.3 | 6.7 | GO:0051321 | meiotic cell cycle(GO:0051321) |
0.3 | 0.3 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.3 | 0.6 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.3 | 2.6 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.3 | 3.9 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.3 | 0.8 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.3 | 1.7 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.3 | 7.8 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.3 | 1.4 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.3 | 0.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 0.3 | GO:0018377 | protein myristoylation(GO:0018377) |
0.3 | 0.8 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.3 | 0.3 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.3 | 0.5 | GO:0071838 | cell proliferation in bone marrow(GO:0071838) regulation of cell proliferation in bone marrow(GO:0071863) positive regulation of cell proliferation in bone marrow(GO:0071864) |
0.3 | 1.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.3 | 5.8 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.3 | 0.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.3 | 0.5 | GO:0006562 | proline catabolic process(GO:0006562) |
0.3 | 0.8 | GO:0060179 | male mating behavior(GO:0060179) |
0.3 | 1.0 | GO:0072666 | protein targeting to vacuole(GO:0006623) establishment of protein localization to vacuole(GO:0072666) |
0.3 | 45.7 | GO:0006412 | translation(GO:0006412) |
0.3 | 0.5 | GO:0001556 | oocyte maturation(GO:0001556) |
0.3 | 0.3 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.3 | 0.3 | GO:0051645 | Golgi localization(GO:0051645) |
0.3 | 20.8 | GO:0032259 | methylation(GO:0032259) |
0.3 | 0.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.3 | 2.0 | GO:0044804 | nucleophagy(GO:0044804) |
0.3 | 0.3 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.2 | 0.2 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.2 | 0.7 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.2 | 0.2 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.2 | 1.7 | GO:0006582 | melanin metabolic process(GO:0006582) |
0.2 | 0.7 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 2.4 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.2 | 1.0 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 0.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.2 | 2.6 | GO:0006818 | hydrogen transport(GO:0006818) |
0.2 | 0.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.2 | 3.0 | GO:0002687 | positive regulation of leukocyte migration(GO:0002687) |
0.2 | 0.7 | GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.2 | 14.3 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.2 | 0.5 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.2 | 0.5 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.2 | 0.7 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.2 | 0.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 0.2 | GO:0090224 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.2 | 0.2 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.2 | 0.7 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.2 | 0.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 0.4 | GO:0071321 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.2 | 3.9 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.2 | 0.2 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.2 | 0.4 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.2 | 7.6 | GO:0006486 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) |
0.2 | 0.2 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.2 | 0.4 | GO:0006591 | ornithine metabolic process(GO:0006591) regulation of L-arginine import(GO:0010963) |
0.2 | 0.2 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.2 | 0.4 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.2 | 0.4 | GO:0001912 | positive regulation of leukocyte mediated cytotoxicity(GO:0001912) |
0.2 | 0.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 0.2 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.2 | 0.2 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.2 | 0.4 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.2 | 3.1 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.2 | 1.2 | GO:0033233 | regulation of protein sumoylation(GO:0033233) |
0.2 | 0.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.2 | 0.9 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.2 | 0.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 1.8 | GO:1901998 | toxin transport(GO:1901998) |
0.2 | 0.2 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.2 | 0.2 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.2 | 0.2 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.2 | 2.5 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.2 | 0.2 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 1.3 | GO:0046677 | response to antibiotic(GO:0046677) |
0.2 | 1.1 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.2 | 0.3 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.2 | 0.9 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 1.6 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.1 | 1.7 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.1 | 0.6 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.1 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 15.8 | GO:0051603 | proteolysis involved in cellular protein catabolic process(GO:0051603) |
0.1 | 0.9 | GO:1901739 | regulation of myoblast fusion(GO:1901739) |
0.1 | 0.1 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 0.1 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.1 | 0.2 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.1 | 0.4 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.2 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.1 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.1 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.1 | 0.1 | GO:0001878 | response to yeast(GO:0001878) |
0.1 | 0.1 | GO:0060596 | mammary placode formation(GO:0060596) |
0.1 | 0.3 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.3 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.1 | 0.5 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.1 | 0.8 | GO:0046466 | membrane lipid catabolic process(GO:0046466) |
0.1 | 0.3 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.1 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.1 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.1 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.1 | 0.4 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 1.3 | GO:0042100 | B cell proliferation(GO:0042100) |
0.1 | 0.1 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 0.1 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.1 | 0.5 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.5 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.1 | 1.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.1 | GO:2000318 | regulation of T-helper 17 type immune response(GO:2000316) positive regulation of T-helper 17 type immune response(GO:2000318) |
0.1 | 95.6 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.1 | 8.8 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 4.0 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.1 | 0.9 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.1 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.1 | 1.2 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.2 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.1 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.7 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.1 | GO:0042506 | tyrosine phosphorylation of Stat5 protein(GO:0042506) |
0.1 | 0.1 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.3 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.1 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
0.1 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.1 | GO:0051593 | response to folic acid(GO:0051593) |
0.1 | 0.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 0.1 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.5 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.1 | 0.1 | GO:0098856 | intestinal lipid absorption(GO:0098856) |
0.1 | 0.1 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.2 | GO:0010332 | response to gamma radiation(GO:0010332) |
0.1 | 0.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.4 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 0.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.1 | GO:0042439 | ethanolamine-containing compound metabolic process(GO:0042439) |
0.1 | 0.1 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) connective tissue replacement(GO:0097709) |
0.0 | 0.0 | GO:0043094 | cellular metabolic compound salvage(GO:0043094) |
0.0 | 0.0 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.0 | 0.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.1 | GO:0006650 | glycerophospholipid metabolic process(GO:0006650) |
0.0 | 0.0 | GO:0051197 | positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.0 | 0.0 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.0 | 0.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.0 | 0.0 | GO:0002891 | positive regulation of B cell mediated immunity(GO:0002714) positive regulation of immunoglobulin mediated immune response(GO:0002891) |
0.0 | 0.0 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.0 | 0.1 | GO:0001842 | neural fold formation(GO:0001842) |
0.0 | 0.0 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.1 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.0 | GO:2001271 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.6 | 99.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
11.4 | 56.9 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
9.5 | 28.5 | GO:0097451 | glial limiting end-foot(GO:0097451) |
9.3 | 28.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
8.3 | 8.3 | GO:0097450 | astrocyte end-foot(GO:0097450) |
8.1 | 32.5 | GO:1990130 | Iml1 complex(GO:1990130) |
6.8 | 6.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
6.8 | 20.4 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
6.5 | 19.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
6.5 | 38.8 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
5.6 | 28.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
5.6 | 16.7 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
5.5 | 27.6 | GO:0097433 | dense body(GO:0097433) |
5.2 | 15.5 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
5.0 | 14.9 | GO:0097413 | Lewy body(GO:0097413) |
4.9 | 19.5 | GO:0005667 | transcription factor complex(GO:0005667) |
4.7 | 14.2 | GO:0046691 | intracellular canaliculus(GO:0046691) |
4.6 | 22.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
4.4 | 13.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
4.4 | 35.3 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
4.3 | 13.0 | GO:0097427 | microtubule bundle(GO:0097427) |
4.2 | 21.1 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
4.2 | 4.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
4.1 | 16.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
4.0 | 4.0 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
4.0 | 11.9 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
4.0 | 15.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
4.0 | 27.7 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
4.0 | 15.8 | GO:0031094 | platelet dense tubular network(GO:0031094) |
3.9 | 15.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
3.9 | 23.4 | GO:0071986 | Ragulator complex(GO:0071986) |
3.9 | 7.7 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
3.8 | 23.1 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
3.8 | 15.4 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
3.8 | 19.2 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
3.8 | 38.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
3.8 | 15.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
3.7 | 7.4 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
3.7 | 3.7 | GO:0000938 | GARP complex(GO:0000938) |
3.5 | 35.2 | GO:0031010 | ISWI-type complex(GO:0031010) |
3.5 | 10.4 | GO:0031523 | Myb complex(GO:0031523) |
3.4 | 13.8 | GO:0072487 | MSL complex(GO:0072487) |
3.4 | 13.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
3.4 | 10.2 | GO:0042827 | platelet dense granule(GO:0042827) |
3.4 | 10.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
3.4 | 10.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
3.4 | 10.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
3.3 | 13.3 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
3.3 | 16.6 | GO:0031298 | replication fork protection complex(GO:0031298) |
3.3 | 13.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
3.2 | 6.5 | GO:0002139 | stereocilia coupling link(GO:0002139) |
3.2 | 87.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
3.2 | 15.9 | GO:0032133 | chromosome passenger complex(GO:0032133) |
3.2 | 22.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
3.1 | 31.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
3.1 | 9.3 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
3.1 | 3.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
3.1 | 3.1 | GO:0045298 | tubulin complex(GO:0045298) |
3.1 | 46.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
3.1 | 9.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
3.0 | 3.0 | GO:0042788 | polysomal ribosome(GO:0042788) |
3.0 | 12.0 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
3.0 | 12.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
3.0 | 11.8 | GO:0098536 | deuterosome(GO:0098536) |
3.0 | 3.0 | GO:0000811 | GINS complex(GO:0000811) |
3.0 | 44.3 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
2.9 | 11.8 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
2.9 | 11.7 | GO:0036449 | microtubule minus-end(GO:0036449) |
2.9 | 8.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
2.9 | 8.6 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
2.8 | 2.8 | GO:0097512 | cardiac myofibril(GO:0097512) |
2.8 | 19.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
2.8 | 8.4 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
2.8 | 2.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
2.8 | 16.6 | GO:0005818 | aster(GO:0005818) |
2.8 | 159.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
2.7 | 21.9 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
2.7 | 10.8 | GO:0033269 | internode region of axon(GO:0033269) |
2.7 | 29.6 | GO:0031941 | filamentous actin(GO:0031941) |
2.7 | 13.5 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
2.7 | 26.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
2.7 | 2.7 | GO:0035371 | microtubule plus-end(GO:0035371) |
2.7 | 10.7 | GO:0005642 | annulate lamellae(GO:0005642) |
2.7 | 5.3 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
2.7 | 21.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
2.7 | 18.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
2.6 | 2.6 | GO:0089701 | U2AF(GO:0089701) |
2.6 | 23.5 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
2.6 | 18.0 | GO:0001650 | fibrillar center(GO:0001650) |
2.5 | 12.7 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
2.5 | 20.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
2.5 | 35.3 | GO:0001891 | phagocytic cup(GO:0001891) |
2.5 | 20.1 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
2.5 | 15.0 | GO:0031415 | NatA complex(GO:0031415) |
2.5 | 2.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
2.5 | 12.4 | GO:0097422 | tubular endosome(GO:0097422) |
2.4 | 9.7 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
2.4 | 9.6 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
2.4 | 9.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
2.4 | 9.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
2.4 | 82.4 | GO:0016592 | mediator complex(GO:0016592) |
2.4 | 21.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
2.3 | 7.0 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
2.3 | 16.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
2.3 | 23.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
2.3 | 7.0 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
2.3 | 9.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
2.3 | 6.8 | GO:0005745 | m-AAA complex(GO:0005745) |
2.2 | 15.7 | GO:0044232 | organelle membrane contact site(GO:0044232) |
2.2 | 31.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
2.2 | 8.9 | GO:0071797 | LUBAC complex(GO:0071797) |
2.2 | 98.2 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
2.2 | 6.7 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
2.2 | 17.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
2.2 | 6.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
2.2 | 6.6 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
2.2 | 8.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
2.2 | 13.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
2.2 | 19.6 | GO:0005869 | dynactin complex(GO:0005869) |
2.2 | 8.7 | GO:0000805 | X chromosome(GO:0000805) |
2.2 | 28.2 | GO:0030914 | STAGA complex(GO:0030914) |
2.2 | 15.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
2.2 | 30.3 | GO:0030904 | retromer complex(GO:0030904) |
2.2 | 15.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
2.1 | 49.4 | GO:0097228 | sperm principal piece(GO:0097228) |
2.1 | 19.2 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
2.1 | 27.7 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
2.1 | 2.1 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
2.1 | 12.8 | GO:0001939 | female pronucleus(GO:0001939) |
2.1 | 25.4 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
2.1 | 8.4 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
2.1 | 2.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
2.1 | 18.9 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
2.1 | 6.3 | GO:0036396 | MIS complex(GO:0036396) |
2.1 | 16.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
2.1 | 6.2 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
2.1 | 22.8 | GO:0032039 | integrator complex(GO:0032039) |
2.1 | 8.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
2.1 | 2.1 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
2.0 | 26.6 | GO:0097440 | apical dendrite(GO:0097440) |
2.0 | 14.3 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
2.0 | 6.1 | GO:0030891 | VCB complex(GO:0030891) |
2.0 | 69.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
2.0 | 89.2 | GO:0005643 | nuclear pore(GO:0005643) |
2.0 | 30.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
2.0 | 8.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
2.0 | 44.0 | GO:0090544 | BAF-type complex(GO:0090544) |
2.0 | 8.0 | GO:0070545 | PeBoW complex(GO:0070545) |
2.0 | 14.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
2.0 | 23.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
2.0 | 129.5 | GO:0016363 | nuclear matrix(GO:0016363) |
2.0 | 10.0 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
2.0 | 31.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
2.0 | 2.0 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
2.0 | 25.7 | GO:0031083 | BLOC-1 complex(GO:0031083) |
2.0 | 9.9 | GO:0005683 | U7 snRNP(GO:0005683) |
2.0 | 15.7 | GO:0034464 | BBSome(GO:0034464) |
2.0 | 7.8 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
1.9 | 13.6 | GO:0010369 | chromocenter(GO:0010369) |
1.9 | 13.6 | GO:0032797 | SMN complex(GO:0032797) |
1.9 | 30.9 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
1.9 | 7.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.9 | 3.8 | GO:0016234 | inclusion body(GO:0016234) |
1.9 | 5.8 | GO:0070876 | SOSS complex(GO:0070876) |
1.9 | 9.6 | GO:0000796 | condensin complex(GO:0000796) |
1.9 | 15.2 | GO:0070652 | HAUS complex(GO:0070652) |
1.9 | 3.8 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
1.9 | 20.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
1.9 | 9.3 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
1.9 | 87.2 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
1.9 | 5.6 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
1.9 | 25.9 | GO:0031528 | microvillus membrane(GO:0031528) |
1.9 | 85.1 | GO:0000502 | proteasome complex(GO:0000502) |
1.8 | 11.1 | GO:0034709 | methylosome(GO:0034709) |
1.8 | 5.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.8 | 165.9 | GO:0072562 | blood microparticle(GO:0072562) |
1.8 | 40.1 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
1.8 | 12.8 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
1.8 | 12.7 | GO:0005686 | U2 snRNP(GO:0005686) |
1.8 | 5.4 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
1.8 | 12.5 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
1.8 | 1.8 | GO:0016939 | kinesin II complex(GO:0016939) |
1.8 | 31.9 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
1.8 | 5.3 | GO:0071817 | MMXD complex(GO:0071817) |
1.8 | 17.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
1.7 | 8.7 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
1.7 | 7.0 | GO:0042575 | DNA polymerase complex(GO:0042575) |
1.7 | 26.2 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
1.7 | 29.6 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
1.7 | 10.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
1.7 | 3.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
1.7 | 5.2 | GO:0005955 | calcineurin complex(GO:0005955) |
1.7 | 18.9 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.7 | 147.6 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
1.7 | 5.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
1.7 | 29.0 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
1.7 | 6.8 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
1.7 | 3.4 | GO:0043198 | dendritic shaft(GO:0043198) |
1.7 | 8.4 | GO:0005827 | polar microtubule(GO:0005827) |
1.7 | 38.5 | GO:0015030 | Cajal body(GO:0015030) |
1.7 | 26.7 | GO:0034451 | centriolar satellite(GO:0034451) |
1.7 | 19.9 | GO:0000242 | pericentriolar material(GO:0000242) |
1.7 | 5.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.7 | 24.8 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
1.7 | 13.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
1.7 | 5.0 | GO:0044295 | axonal growth cone(GO:0044295) |
1.6 | 19.8 | GO:0044292 | dendrite terminus(GO:0044292) |
1.6 | 6.6 | GO:1990246 | uniplex complex(GO:1990246) |
1.6 | 6.6 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
1.6 | 4.9 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
1.6 | 11.4 | GO:0000124 | SAGA complex(GO:0000124) |
1.6 | 14.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
1.6 | 3.2 | GO:1990923 | PET complex(GO:1990923) |
1.6 | 24.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
1.6 | 4.8 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
1.6 | 12.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
1.6 | 4.7 | GO:0097452 | GAIT complex(GO:0097452) |
1.6 | 7.8 | GO:0034704 | calcium channel complex(GO:0034704) |
1.6 | 1.6 | GO:0005688 | U6 snRNP(GO:0005688) |
1.6 | 6.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
1.5 | 6.1 | GO:0035339 | SPOTS complex(GO:0035339) |
1.5 | 32.0 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
1.5 | 10.5 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
1.5 | 6.0 | GO:0005682 | U5 snRNP(GO:0005682) |
1.5 | 7.5 | GO:0070688 | MLL5-L complex(GO:0070688) |
1.5 | 5.9 | GO:0072687 | meiotic spindle(GO:0072687) |
1.5 | 56.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.5 | 1.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
1.5 | 2.9 | GO:0032010 | phagolysosome(GO:0032010) |
1.5 | 1.5 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
1.5 | 4.4 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
1.5 | 5.8 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
1.5 | 10.2 | GO:0016272 | prefoldin complex(GO:0016272) |
1.4 | 1.4 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
1.4 | 7.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
1.4 | 2.8 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
1.4 | 5.7 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
1.4 | 9.9 | GO:1990909 | Wnt signalosome(GO:1990909) |
1.4 | 79.6 | GO:0005795 | Golgi stack(GO:0005795) |
1.4 | 5.7 | GO:0002177 | manchette(GO:0002177) |
1.4 | 14.2 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.4 | 92.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
1.4 | 2.8 | GO:0032300 | mismatch repair complex(GO:0032300) |
1.4 | 5.6 | GO:0030689 | Noc complex(GO:0030689) |
1.4 | 11.2 | GO:0042555 | MCM complex(GO:0042555) |
1.4 | 26.5 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
1.4 | 4.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
1.4 | 2.8 | GO:0033186 | CAF-1 complex(GO:0033186) |
1.4 | 4.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
1.4 | 6.8 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
1.4 | 25.9 | GO:0005776 | autophagosome(GO:0005776) |
1.4 | 49.0 | GO:0022627 | small ribosomal subunit(GO:0015935) cytosolic small ribosomal subunit(GO:0022627) |
1.4 | 2.7 | GO:0005927 | muscle tendon junction(GO:0005927) |
1.4 | 4.1 | GO:0030478 | actin cap(GO:0030478) |
1.4 | 5.4 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
1.4 | 9.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
1.4 | 10.8 | GO:0042581 | specific granule(GO:0042581) |
1.4 | 4.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
1.3 | 21.5 | GO:0000145 | exocyst(GO:0000145) |
1.3 | 1.3 | GO:0097470 | ribbon synapse(GO:0097470) |
1.3 | 10.7 | GO:0031011 | Ino80 complex(GO:0031011) |
1.3 | 17.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
1.3 | 54.8 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
1.3 | 13.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.3 | 14.6 | GO:1902555 | endoribonuclease complex(GO:1902555) |
1.3 | 33.0 | GO:0005771 | multivesicular body(GO:0005771) |
1.3 | 1.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
1.3 | 9.2 | GO:0031931 | TORC1 complex(GO:0031931) |
1.3 | 9.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.3 | 60.2 | GO:0005811 | lipid particle(GO:0005811) |
1.3 | 40.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
1.3 | 20.8 | GO:0005876 | spindle microtubule(GO:0005876) |
1.3 | 7.8 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
1.3 | 7.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
1.3 | 2.6 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
1.3 | 12.9 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
1.3 | 46.3 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
1.3 | 9.0 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
1.3 | 30.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
1.3 | 102.0 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
1.3 | 16.6 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.3 | 7.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
1.3 | 5.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.3 | 22.8 | GO:0016235 | aggresome(GO:0016235) |
1.3 | 5.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
1.3 | 2.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
1.3 | 10.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
1.3 | 15.1 | GO:0030894 | replisome(GO:0030894) |
1.3 | 16.4 | GO:0035861 | site of double-strand break(GO:0035861) |
1.3 | 6.3 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
1.2 | 7.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
1.2 | 7.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
1.2 | 6.1 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
1.2 | 11.0 | GO:0070938 | contractile ring(GO:0070938) |
1.2 | 8.6 | GO:0045120 | pronucleus(GO:0045120) |
1.2 | 326.0 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
1.2 | 7.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.2 | 51.2 | GO:0016605 | PML body(GO:0016605) |
1.2 | 182.8 | GO:0005759 | mitochondrial matrix(GO:0005759) |
1.2 | 33.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
1.2 | 3.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.2 | 3.6 | GO:0090543 | Flemming body(GO:0090543) |
1.2 | 8.4 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
1.2 | 13.2 | GO:0005657 | replication fork(GO:0005657) |
1.2 | 8.4 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
1.2 | 3.6 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
1.2 | 9.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
1.2 | 27.0 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
1.2 | 15.2 | GO:0034399 | nuclear periphery(GO:0034399) |
1.2 | 9.3 | GO:0002102 | podosome(GO:0002102) |
1.2 | 3.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.1 | 14.9 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
1.1 | 4.6 | GO:0030008 | TRAPP complex(GO:0030008) |
1.1 | 2.3 | GO:0019814 | immunoglobulin complex(GO:0019814) |
1.1 | 1.1 | GO:0045293 | mRNA editing complex(GO:0045293) |
1.1 | 7.9 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
1.1 | 28.3 | GO:0031201 | SNARE complex(GO:0031201) |
1.1 | 1.1 | GO:0070695 | FHF complex(GO:0070695) |
1.1 | 2.2 | GO:0000974 | Prp19 complex(GO:0000974) |
1.1 | 1.1 | GO:0097255 | R2TP complex(GO:0097255) |
1.1 | 81.4 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
1.1 | 2.2 | GO:0070069 | cytochrome complex(GO:0070069) |
1.1 | 3.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
1.1 | 7.7 | GO:0060091 | kinocilium(GO:0060091) |
1.1 | 3.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
1.1 | 4.4 | GO:0032389 | MutLalpha complex(GO:0032389) |
1.1 | 3.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
1.1 | 21.6 | GO:0001772 | immunological synapse(GO:0001772) |
1.1 | 9.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
1.1 | 2.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
1.1 | 3.2 | GO:0043203 | axon hillock(GO:0043203) |
1.1 | 9.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
1.1 | 28.7 | GO:1990204 | oxidoreductase complex(GO:1990204) |
1.1 | 2.1 | GO:0031512 | motile primary cilium(GO:0031512) |
1.1 | 20.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
1.0 | 6.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
1.0 | 2.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
1.0 | 13.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
1.0 | 3.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
1.0 | 67.3 | GO:0016604 | nuclear body(GO:0016604) |
1.0 | 40.2 | GO:0000922 | spindle pole(GO:0000922) |
1.0 | 181.5 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
1.0 | 7.2 | GO:0000346 | transcription export complex(GO:0000346) |
1.0 | 38.7 | GO:0000793 | condensed chromosome(GO:0000793) |
1.0 | 1.0 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
1.0 | 40.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
1.0 | 3.0 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.0 | 22.1 | GO:0035869 | ciliary transition zone(GO:0035869) |
1.0 | 37.0 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
1.0 | 3.0 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
1.0 | 25.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
1.0 | 2.0 | GO:0044299 | C-fiber(GO:0044299) |
1.0 | 2.0 | GO:0030990 | intraciliary transport particle(GO:0030990) |
1.0 | 2.9 | GO:0005879 | axonemal microtubule(GO:0005879) |
1.0 | 6.8 | GO:0044853 | plasma membrane raft(GO:0044853) |
1.0 | 25.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
1.0 | 2.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.0 | 16.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
1.0 | 3.9 | GO:0005775 | vacuolar lumen(GO:0005775) |
1.0 | 2.9 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
1.0 | 36.3 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.9 | 28.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.9 | 3.8 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.9 | 38.9 | GO:0098687 | chromosomal region(GO:0098687) |
0.9 | 15.9 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.9 | 38.9 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.9 | 31.4 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.9 | 5.5 | GO:0030175 | filopodium(GO:0030175) |
0.9 | 29.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.9 | 6.4 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.9 | 3.7 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.9 | 73.1 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
0.9 | 246.1 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.9 | 4.5 | GO:0071437 | invadopodium(GO:0071437) |
0.9 | 4.5 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.9 | 706.1 | GO:0005739 | mitochondrion(GO:0005739) |
0.9 | 24.9 | GO:0005819 | spindle(GO:0005819) |
0.9 | 741.2 | GO:0005654 | nucleoplasm(GO:0005654) |
0.9 | 11.4 | GO:0005844 | polysome(GO:0005844) |
0.9 | 0.9 | GO:0035102 | PRC1 complex(GO:0035102) |
0.9 | 15.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.9 | 1.7 | GO:0097443 | sorting endosome(GO:0097443) |
0.9 | 3.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.9 | 6.8 | GO:0032426 | stereocilium tip(GO:0032426) |
0.9 | 6.8 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.9 | 10.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.8 | 10.2 | GO:0012506 | vesicle membrane(GO:0012506) |
0.8 | 15.2 | GO:0032040 | small-subunit processome(GO:0032040) |
0.8 | 2.5 | GO:0031417 | NatC complex(GO:0031417) |
0.8 | 4.2 | GO:0071546 | pi-body(GO:0071546) |
0.8 | 3.3 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.8 | 0.8 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.8 | 0.8 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.8 | 0.8 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.8 | 1.6 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.8 | 11.2 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.8 | 2.4 | GO:0032584 | growth cone membrane(GO:0032584) |
0.8 | 3.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.8 | 2.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.8 | 3.1 | GO:0016459 | myosin complex(GO:0016459) |
0.7 | 3.7 | GO:0016600 | flotillin complex(GO:0016600) |
0.7 | 433.3 | GO:0005829 | cytosol(GO:0005829) |
0.7 | 1.5 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.7 | 1.4 | GO:1990391 | DNA repair complex(GO:1990391) |
0.7 | 3.6 | GO:1904949 | ATPase complex(GO:1904949) |
0.7 | 2.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.7 | 4.3 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.7 | 0.7 | GO:0014704 | intercalated disc(GO:0014704) |
0.7 | 64.0 | GO:0005635 | nuclear envelope(GO:0005635) |
0.7 | 2.1 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.7 | 1.3 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.7 | 0.7 | GO:0043196 | varicosity(GO:0043196) |
0.7 | 2.6 | GO:1990745 | EARP complex(GO:1990745) |
0.6 | 0.6 | GO:0072534 | perineuronal net(GO:0072534) |
0.6 | 1.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.6 | 6.4 | GO:0072372 | primary cilium(GO:0072372) |
0.6 | 2.5 | GO:0030496 | midbody(GO:0030496) |
0.6 | 22.0 | GO:0034707 | chloride channel complex(GO:0034707) |
0.6 | 4.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.6 | 126.8 | GO:0005730 | nucleolus(GO:0005730) |
0.6 | 12.2 | GO:0008305 | integrin complex(GO:0008305) |
0.6 | 1.2 | GO:0046930 | membrane attack complex(GO:0005579) pore complex(GO:0046930) |
0.6 | 1.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.6 | 3.0 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.6 | 80.1 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.6 | 2.8 | GO:0043083 | synaptic cleft(GO:0043083) |
0.5 | 1.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.5 | 1.6 | GO:0032433 | filopodium tip(GO:0032433) |
0.5 | 0.5 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.5 | 10.8 | GO:0001726 | ruffle(GO:0001726) |
0.5 | 1.6 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.5 | 268.4 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.5 | 1.6 | GO:0031209 | SCAR complex(GO:0031209) |
0.5 | 1.0 | GO:0005883 | neurofilament(GO:0005883) |
0.5 | 2.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.5 | 0.5 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.5 | 10.0 | GO:0043204 | perikaryon(GO:0043204) |
0.5 | 45.0 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.4 | 5.3 | GO:0005773 | vacuole(GO:0005773) |
0.4 | 1.3 | GO:0033270 | paranode region of axon(GO:0033270) |
0.4 | 44.4 | GO:1990234 | transferase complex(GO:1990234) |
0.4 | 2.0 | GO:0030315 | T-tubule(GO:0030315) |
0.4 | 35.1 | GO:0005694 | chromosome(GO:0005694) |
0.4 | 65.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.3 | 3.1 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.3 | 20.0 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.3 | 1.0 | GO:0031430 | M band(GO:0031430) |
0.3 | 0.3 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.3 | 0.3 | GO:0071439 | clathrin complex(GO:0071439) |
0.3 | 190.2 | GO:0012505 | endomembrane system(GO:0012505) |
0.3 | 2.4 | GO:0032420 | stereocilium(GO:0032420) |
0.3 | 462.4 | GO:0005634 | nucleus(GO:0005634) |
0.3 | 15.4 | GO:0005874 | microtubule(GO:0005874) |
0.2 | 0.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 0.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.2 | 15.7 | GO:0043231 | intracellular membrane-bounded organelle(GO:0043231) |
0.2 | 3.9 | GO:0043197 | dendritic spine(GO:0043197) |
0.1 | 2.2 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 1.4 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.1 | 1.5 | GO:1902494 | catalytic complex(GO:1902494) |
0.1 | 0.9 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 281.4 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 64.6 | GO:0005737 | cytoplasm(GO:0005737) |
0.0 | 0.0 | GO:0097386 | glial cell projection(GO:0097386) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.6 | 54.5 | GO:0031720 | haptoglobin binding(GO:0031720) |
11.5 | 34.4 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
11.5 | 34.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
9.5 | 28.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
9.2 | 64.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
7.9 | 39.3 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
7.7 | 53.7 | GO:0019957 | C-C chemokine binding(GO:0019957) |
7.1 | 28.4 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
7.1 | 28.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
7.0 | 21.0 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
6.9 | 20.7 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
6.8 | 20.5 | GO:0004064 | arylesterase activity(GO:0004064) |
6.7 | 20.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
6.5 | 26.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
6.5 | 26.0 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
6.5 | 51.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
6.3 | 18.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
6.3 | 12.6 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
6.1 | 18.3 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
6.0 | 18.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
5.9 | 35.4 | GO:0043559 | insulin binding(GO:0043559) |
5.8 | 17.4 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
5.8 | 23.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
5.7 | 22.8 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
5.7 | 34.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
5.5 | 5.5 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
5.5 | 16.4 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
5.4 | 32.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
5.4 | 21.6 | GO:0042731 | PH domain binding(GO:0042731) |
5.4 | 16.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
5.1 | 25.3 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
5.1 | 106.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
5.0 | 15.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
5.0 | 24.9 | GO:0070728 | leucine binding(GO:0070728) |
5.0 | 14.9 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
4.9 | 14.7 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
4.9 | 39.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
4.8 | 14.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
4.7 | 14.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
4.7 | 23.6 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
4.7 | 4.7 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
4.6 | 13.8 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
4.5 | 26.9 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
4.4 | 13.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
4.4 | 39.4 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
4.4 | 13.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
4.3 | 30.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
4.3 | 8.6 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
4.3 | 12.9 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
4.3 | 17.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
4.3 | 17.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
4.3 | 17.1 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
4.3 | 17.0 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
4.2 | 34.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
4.2 | 16.9 | GO:0009374 | biotin binding(GO:0009374) |
4.2 | 12.5 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
4.1 | 28.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
4.1 | 36.9 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
4.1 | 53.1 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
4.1 | 12.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
4.1 | 24.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
4.0 | 36.3 | GO:0016004 | phospholipase activator activity(GO:0016004) |
4.0 | 8.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
4.0 | 15.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
3.9 | 19.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
3.9 | 11.7 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
3.9 | 19.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
3.8 | 11.5 | GO:0030350 | iron-responsive element binding(GO:0030350) |
3.8 | 11.5 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
3.8 | 84.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
3.7 | 11.2 | GO:0051425 | PTB domain binding(GO:0051425) |
3.7 | 33.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
3.7 | 18.6 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
3.7 | 11.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
3.7 | 29.3 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
3.7 | 11.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
3.6 | 18.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
3.6 | 28.9 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
3.6 | 10.8 | GO:0019961 | interferon binding(GO:0019961) |
3.6 | 10.8 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
3.6 | 17.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
3.5 | 10.6 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
3.5 | 3.5 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
3.5 | 10.6 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
3.5 | 17.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
3.5 | 7.0 | GO:0045503 | dynein light chain binding(GO:0045503) |
3.5 | 10.4 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
3.5 | 38.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
3.5 | 24.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
3.4 | 10.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
3.4 | 16.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
3.4 | 10.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
3.3 | 3.3 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
3.3 | 10.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
3.3 | 13.2 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
3.3 | 13.2 | GO:0015232 | heme transporter activity(GO:0015232) |
3.3 | 13.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
3.3 | 3.3 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
3.2 | 25.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
3.2 | 6.3 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
3.2 | 19.0 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
3.1 | 9.4 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
3.1 | 12.6 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
3.1 | 65.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
3.1 | 25.0 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
3.1 | 9.3 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
3.1 | 9.3 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
3.1 | 9.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
3.1 | 9.2 | GO:0030620 | U2 snRNA binding(GO:0030620) |
3.1 | 9.2 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
3.1 | 33.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
3.1 | 27.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
3.0 | 21.3 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
3.0 | 27.3 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
3.0 | 12.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
3.0 | 9.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
3.0 | 15.0 | GO:0070061 | fructose binding(GO:0070061) |
3.0 | 6.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
3.0 | 6.0 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
3.0 | 11.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
3.0 | 74.0 | GO:0004407 | histone deacetylase activity(GO:0004407) |
2.9 | 14.7 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
2.9 | 11.8 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
2.9 | 2.9 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
2.9 | 11.6 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
2.9 | 8.7 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
2.9 | 14.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
2.9 | 22.9 | GO:0034046 | poly(G) binding(GO:0034046) |
2.8 | 14.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
2.8 | 8.5 | GO:1990460 | leptin receptor binding(GO:1990460) |
2.8 | 11.3 | GO:0030911 | TPR domain binding(GO:0030911) |
2.8 | 41.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
2.8 | 22.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
2.8 | 11.0 | GO:0035473 | lipase binding(GO:0035473) |
2.8 | 11.0 | GO:0050693 | LBD domain binding(GO:0050693) |
2.8 | 35.8 | GO:0001618 | virus receptor activity(GO:0001618) |
2.7 | 2.7 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
2.7 | 13.6 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
2.7 | 5.4 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
2.6 | 23.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
2.6 | 18.3 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
2.6 | 10.4 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
2.6 | 23.3 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
2.6 | 7.8 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
2.6 | 90.1 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
2.6 | 35.9 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
2.6 | 15.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
2.5 | 22.9 | GO:0003993 | acid phosphatase activity(GO:0003993) |
2.5 | 7.6 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
2.5 | 7.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.5 | 47.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
2.5 | 47.3 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
2.5 | 7.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
2.5 | 14.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
2.5 | 7.4 | GO:0071209 | U7 snRNA binding(GO:0071209) |
2.5 | 9.9 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
2.5 | 22.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
2.5 | 12.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
2.5 | 14.7 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
2.5 | 51.5 | GO:0030507 | spectrin binding(GO:0030507) |
2.4 | 26.9 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
2.4 | 9.8 | GO:0043515 | kinetochore binding(GO:0043515) |
2.4 | 19.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
2.4 | 7.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
2.4 | 4.8 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
2.4 | 2.4 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
2.4 | 21.6 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
2.4 | 9.5 | GO:0005123 | death receptor binding(GO:0005123) |
2.4 | 9.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
2.4 | 7.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
2.4 | 14.2 | GO:0035197 | siRNA binding(GO:0035197) |
2.4 | 9.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
2.4 | 68.4 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
2.4 | 25.9 | GO:0035173 | histone kinase activity(GO:0035173) |
2.3 | 7.0 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
2.3 | 7.0 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
2.3 | 2.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
2.3 | 9.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
2.3 | 66.4 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
2.3 | 9.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
2.3 | 6.8 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
2.3 | 9.0 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
2.3 | 11.3 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
2.2 | 6.7 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
2.2 | 9.0 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
2.2 | 6.7 | GO:0097016 | L27 domain binding(GO:0097016) |
2.2 | 8.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
2.2 | 8.9 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
2.2 | 8.8 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
2.2 | 11.0 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
2.2 | 28.4 | GO:0010181 | FMN binding(GO:0010181) |
2.2 | 10.9 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
2.2 | 10.9 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
2.2 | 8.7 | GO:0002060 | purine nucleobase binding(GO:0002060) |
2.2 | 19.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
2.2 | 47.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
2.2 | 23.7 | GO:0043176 | amine binding(GO:0043176) |
2.1 | 4.3 | GO:1990188 | euchromatin binding(GO:1990188) |
2.1 | 10.7 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
2.1 | 4.3 | GO:0043842 | Kdo transferase activity(GO:0043842) |
2.1 | 17.1 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
2.1 | 34.1 | GO:0001848 | complement binding(GO:0001848) |
2.1 | 4.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
2.1 | 17.0 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
2.1 | 4.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
2.1 | 12.8 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
2.1 | 8.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
2.1 | 14.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
2.1 | 6.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
2.1 | 6.3 | GO:1990239 | steroid hormone binding(GO:1990239) |
2.1 | 12.7 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
2.1 | 31.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
2.1 | 2.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
2.1 | 8.4 | GO:0016972 | thiol oxidase activity(GO:0016972) |
2.1 | 18.8 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
2.1 | 2.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
2.1 | 6.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
2.1 | 16.6 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
2.1 | 4.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
2.1 | 55.8 | GO:0004364 | glutathione transferase activity(GO:0004364) |
2.1 | 4.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
2.1 | 65.8 | GO:0004177 | aminopeptidase activity(GO:0004177) |
2.1 | 8.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
2.0 | 18.4 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
2.0 | 6.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
2.0 | 4.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
2.0 | 8.2 | GO:0044682 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
2.0 | 4.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
2.0 | 4.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
2.0 | 6.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
2.0 | 12.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
2.0 | 2.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
2.0 | 24.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
2.0 | 18.3 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
2.0 | 6.1 | GO:0019213 | deacetylase activity(GO:0019213) |
2.0 | 69.0 | GO:0043022 | ribosome binding(GO:0043022) |
2.0 | 6.1 | GO:0030984 | kininogen binding(GO:0030984) |
2.0 | 4.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
2.0 | 6.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
2.0 | 22.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
2.0 | 28.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
2.0 | 14.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
2.0 | 6.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
2.0 | 6.0 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
2.0 | 9.9 | GO:0016151 | nickel cation binding(GO:0016151) |
2.0 | 5.9 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
2.0 | 11.9 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
2.0 | 11.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
2.0 | 5.9 | GO:0050816 | phosphothreonine binding(GO:0050816) |
2.0 | 7.9 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
2.0 | 5.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
2.0 | 7.9 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
2.0 | 13.7 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
2.0 | 5.9 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
2.0 | 7.8 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
2.0 | 5.9 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.9 | 11.7 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
1.9 | 34.8 | GO:0045502 | dynein binding(GO:0045502) |
1.9 | 7.7 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.9 | 5.8 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
1.9 | 3.8 | GO:0015928 | fucosidase activity(GO:0015928) |
1.9 | 3.8 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
1.9 | 9.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
1.9 | 5.7 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
1.9 | 9.5 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
1.9 | 5.7 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.9 | 7.6 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
1.9 | 13.3 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
1.9 | 11.4 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
1.9 | 3.8 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
1.9 | 13.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
1.9 | 56.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
1.9 | 48.7 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
1.9 | 1.9 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
1.9 | 18.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
1.9 | 24.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
1.9 | 5.6 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.8 | 57.3 | GO:0048487 | beta-tubulin binding(GO:0048487) |
1.8 | 3.7 | GO:0000403 | Y-form DNA binding(GO:0000403) |
1.8 | 7.4 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
1.8 | 53.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.8 | 9.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
1.8 | 1.8 | GO:0002054 | nucleobase binding(GO:0002054) |
1.8 | 3.6 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
1.8 | 23.6 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
1.8 | 59.9 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
1.8 | 41.7 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
1.8 | 12.7 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
1.8 | 9.0 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
1.8 | 7.2 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
1.8 | 7.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.8 | 14.4 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.8 | 36.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
1.8 | 41.3 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
1.8 | 3.6 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
1.8 | 17.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
1.8 | 8.9 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
1.8 | 3.6 | GO:0036310 | annealing helicase activity(GO:0036310) |
1.8 | 14.3 | GO:0031386 | protein tag(GO:0031386) |
1.8 | 8.9 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
1.8 | 19.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
1.8 | 23.1 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
1.8 | 31.9 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
1.8 | 7.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
1.8 | 7.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
1.8 | 19.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
1.8 | 3.5 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
1.8 | 8.8 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
1.8 | 8.8 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
1.8 | 7.1 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
1.8 | 5.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
1.8 | 33.4 | GO:0031369 | translation initiation factor binding(GO:0031369) |
1.8 | 35.1 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
1.8 | 35.1 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
1.8 | 5.3 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
1.7 | 3.5 | GO:0089720 | caspase binding(GO:0089720) |
1.7 | 26.1 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
1.7 | 8.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
1.7 | 22.5 | GO:0019825 | oxygen binding(GO:0019825) |
1.7 | 3.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
1.7 | 3.4 | GO:0004359 | glutaminase activity(GO:0004359) |
1.7 | 3.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
1.7 | 18.8 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
1.7 | 12.0 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
1.7 | 37.6 | GO:0000049 | tRNA binding(GO:0000049) |
1.7 | 13.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.7 | 5.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.7 | 72.8 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
1.7 | 27.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
1.7 | 5.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
1.7 | 62.1 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
1.7 | 1.7 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
1.7 | 1.7 | GO:0016595 | glutamate binding(GO:0016595) |
1.7 | 1.7 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
1.7 | 33.2 | GO:0030331 | estrogen receptor binding(GO:0030331) |
1.6 | 3.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
1.6 | 4.9 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
1.6 | 6.6 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
1.6 | 36.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
1.6 | 1.6 | GO:0034618 | arginine binding(GO:0034618) |
1.6 | 92.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
1.6 | 8.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
1.6 | 1.6 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
1.6 | 43.8 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
1.6 | 8.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
1.6 | 11.3 | GO:0032183 | SUMO binding(GO:0032183) |
1.6 | 21.0 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
1.6 | 4.9 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
1.6 | 8.1 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
1.6 | 4.8 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
1.6 | 8.0 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
1.6 | 44.4 | GO:0015485 | cholesterol binding(GO:0015485) |
1.6 | 42.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
1.6 | 11.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
1.6 | 23.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
1.6 | 7.8 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
1.6 | 4.7 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
1.6 | 10.9 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
1.5 | 15.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
1.5 | 12.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
1.5 | 6.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
1.5 | 10.7 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
1.5 | 6.1 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
1.5 | 113.3 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
1.5 | 18.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
1.5 | 117.3 | GO:0002020 | protease binding(GO:0002020) |
1.5 | 27.0 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
1.5 | 6.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.5 | 3.0 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
1.5 | 4.5 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
1.5 | 11.9 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
1.5 | 11.9 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
1.5 | 8.9 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
1.5 | 5.9 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
1.5 | 57.7 | GO:0019209 | kinase activator activity(GO:0019209) |
1.5 | 1.5 | GO:0070698 | type I activin receptor binding(GO:0070698) |
1.5 | 3.0 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
1.5 | 13.3 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
1.5 | 7.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
1.5 | 5.9 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
1.5 | 1.5 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
1.5 | 4.4 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.5 | 17.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
1.5 | 16.0 | GO:0050681 | androgen receptor binding(GO:0050681) |
1.4 | 4.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
1.4 | 14.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
1.4 | 5.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
1.4 | 2.8 | GO:0030492 | hemoglobin binding(GO:0030492) |
1.4 | 2.8 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
1.4 | 4.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.4 | 5.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.4 | 7.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.4 | 1.4 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
1.4 | 14.0 | GO:0004568 | chitinase activity(GO:0004568) |
1.4 | 4.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
1.4 | 15.3 | GO:0036222 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
1.4 | 6.9 | GO:0008432 | JUN kinase binding(GO:0008432) |
1.4 | 13.8 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
1.4 | 2.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.4 | 44.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
1.4 | 4.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
1.4 | 40.9 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
1.4 | 5.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
1.4 | 5.4 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
1.4 | 5.4 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
1.4 | 5.4 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.4 | 5.4 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
1.3 | 1.3 | GO:0035514 | DNA demethylase activity(GO:0035514) |
1.3 | 5.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
1.3 | 14.7 | GO:0005521 | lamin binding(GO:0005521) |
1.3 | 18.7 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
1.3 | 1.3 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
1.3 | 5.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
1.3 | 9.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
1.3 | 5.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.3 | 7.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.3 | 7.9 | GO:0031491 | nucleosome binding(GO:0031491) |
1.3 | 1.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
1.3 | 3.9 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
1.3 | 3.9 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.3 | 15.8 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
1.3 | 6.6 | GO:0031996 | thioesterase binding(GO:0031996) |
1.3 | 2.6 | GO:0034452 | dynactin binding(GO:0034452) |
1.3 | 26.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
1.3 | 5.2 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
1.3 | 5.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
1.3 | 15.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
1.3 | 36.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
1.3 | 36.2 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
1.3 | 10.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
1.3 | 60.3 | GO:0016836 | hydro-lyase activity(GO:0016836) |
1.3 | 3.8 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
1.3 | 3.8 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
1.3 | 16.5 | GO:0001221 | transcription cofactor binding(GO:0001221) |
1.3 | 19.0 | GO:0015925 | galactosidase activity(GO:0015925) |
1.3 | 134.2 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
1.3 | 36.6 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
1.3 | 114.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
1.3 | 2.5 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
1.3 | 17.6 | GO:0016594 | glycine binding(GO:0016594) |
1.3 | 18.9 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
1.3 | 5.0 | GO:0004521 | endoribonuclease activity(GO:0004521) |
1.3 | 27.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
1.3 | 3.8 | GO:0016015 | morphogen activity(GO:0016015) |
1.3 | 18.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
1.2 | 16.2 | GO:0008252 | nucleotidase activity(GO:0008252) |
1.2 | 8.7 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
1.2 | 11.2 | GO:0070628 | proteasome binding(GO:0070628) |
1.2 | 7.5 | GO:0070513 | death domain binding(GO:0070513) |
1.2 | 5.0 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
1.2 | 22.3 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
1.2 | 3.7 | GO:0008312 | 7S RNA binding(GO:0008312) |
1.2 | 16.1 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
1.2 | 4.9 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
1.2 | 4.9 | GO:0004645 | phosphorylase activity(GO:0004645) |
1.2 | 23.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.2 | 3.7 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.2 | 217.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
1.2 | 152.9 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
1.2 | 3.6 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
1.2 | 12.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
1.2 | 2.4 | GO:0004104 | cholinesterase activity(GO:0004104) |
1.2 | 1.2 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
1.2 | 12.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.2 | 2.4 | GO:0015248 | sterol transporter activity(GO:0015248) |
1.2 | 3.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.2 | 2.4 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
1.2 | 4.8 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
1.2 | 5.9 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
1.2 | 1.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
1.2 | 2.4 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.2 | 5.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
1.2 | 10.5 | GO:0034522 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
1.2 | 3.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
1.2 | 18.7 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
1.2 | 1.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
1.2 | 18.6 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
1.2 | 8.1 | GO:0042300 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
1.2 | 6.9 | GO:0033613 | activating transcription factor binding(GO:0033613) |
1.2 | 3.5 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
1.2 | 9.2 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
1.2 | 49.6 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
1.1 | 3.4 | GO:0015288 | porin activity(GO:0015288) |
1.1 | 3.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
1.1 | 3.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.1 | 12.5 | GO:0008242 | omega peptidase activity(GO:0008242) |
1.1 | 18.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
1.1 | 3.4 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
1.1 | 19.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
1.1 | 5.6 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
1.1 | 7.9 | GO:0070182 | DNA polymerase binding(GO:0070182) |
1.1 | 4.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
1.1 | 6.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
1.1 | 11.2 | GO:0030955 | potassium ion binding(GO:0030955) |
1.1 | 46.0 | GO:0051087 | chaperone binding(GO:0051087) |
1.1 | 2.2 | GO:0019862 | IgA binding(GO:0019862) |
1.1 | 2.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
1.1 | 2.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
1.1 | 9.9 | GO:0070402 | NADPH binding(GO:0070402) |
1.1 | 1.1 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) quaternary ammonium group transmembrane transporter activity(GO:0015651) |
1.1 | 16.3 | GO:0030145 | manganese ion binding(GO:0030145) |
1.1 | 2.2 | GO:0034838 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
1.1 | 3.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
1.1 | 23.5 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
1.1 | 2.1 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
1.1 | 29.9 | GO:0002039 | p53 binding(GO:0002039) |
1.1 | 3.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.1 | 4.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
1.1 | 38.1 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
1.1 | 3.2 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
1.1 | 15.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
1.0 | 6.3 | GO:0050700 | CARD domain binding(GO:0050700) |
1.0 | 11.5 | GO:0019841 | retinol binding(GO:0019841) |
1.0 | 15.6 | GO:0032451 | demethylase activity(GO:0032451) |
1.0 | 3.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.0 | 52.9 | GO:0003724 | RNA helicase activity(GO:0003724) |
1.0 | 2.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
1.0 | 3.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
1.0 | 7.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.0 | 9.3 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
1.0 | 1.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
1.0 | 5.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
1.0 | 4.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
1.0 | 11.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
1.0 | 6.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
1.0 | 5.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.0 | 4.0 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
1.0 | 4.0 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
1.0 | 10.1 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
1.0 | 3.0 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
1.0 | 3.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
1.0 | 10.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
1.0 | 9.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
1.0 | 3.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.0 | 6.0 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
1.0 | 2.0 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
1.0 | 5.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
1.0 | 8.9 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
1.0 | 1.0 | GO:0016531 | copper chaperone activity(GO:0016531) |
1.0 | 3.9 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
1.0 | 11.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
1.0 | 11.6 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
1.0 | 54.9 | GO:0004519 | endonuclease activity(GO:0004519) |
1.0 | 2.9 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.9 | 4.7 | GO:0016209 | antioxidant activity(GO:0016209) |
0.9 | 0.9 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.9 | 2.8 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.9 | 3.8 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.9 | 1.9 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.9 | 2.8 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.9 | 4.6 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.9 | 1.8 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.9 | 17.5 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.9 | 10.1 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.9 | 1.8 | GO:0000339 | RNA cap binding(GO:0000339) |
0.9 | 1.8 | GO:0008194 | UDP-glycosyltransferase activity(GO:0008194) |
0.9 | 4.6 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.9 | 11.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.9 | 4.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.9 | 1.8 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.9 | 0.9 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.9 | 4.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.9 | 5.4 | GO:1990405 | protein antigen binding(GO:1990405) |
0.9 | 0.9 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.9 | 27.7 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.9 | 1.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.9 | 7.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.9 | 49.3 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.9 | 2.6 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.9 | 40.2 | GO:0008565 | protein transporter activity(GO:0008565) |
0.9 | 3.4 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.9 | 21.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.9 | 1.7 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.9 | 1.7 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.8 | 3.4 | GO:0038100 | nodal binding(GO:0038100) |
0.8 | 0.8 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.8 | 4.2 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.8 | 1.7 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.8 | 22.8 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.8 | 6.7 | GO:0043531 | ADP binding(GO:0043531) |
0.8 | 10.9 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.8 | 19.3 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.8 | 2.5 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.8 | 2.5 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.8 | 1.6 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.8 | 8.2 | GO:0031404 | chloride ion binding(GO:0031404) |
0.8 | 4.1 | GO:0005536 | glucose binding(GO:0005536) |
0.8 | 0.8 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.8 | 4.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.8 | 4.9 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.8 | 17.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.8 | 23.6 | GO:0005507 | copper ion binding(GO:0005507) |
0.8 | 50.4 | GO:0042393 | histone binding(GO:0042393) |
0.8 | 4.9 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.8 | 0.8 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.8 | 4.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.8 | 4.1 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.8 | 17.0 | GO:0004386 | helicase activity(GO:0004386) |
0.8 | 8.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.8 | 3.2 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.8 | 8.0 | GO:0030506 | ankyrin binding(GO:0030506) |
0.8 | 7.1 | GO:0017069 | snRNA binding(GO:0017069) |
0.8 | 3.9 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.8 | 16.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.8 | 7.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.8 | 1.5 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.8 | 0.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.8 | 0.8 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.8 | 1.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.8 | 3.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.8 | 10.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.8 | 54.8 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.8 | 1.5 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.8 | 2.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.8 | 9.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.7 | 6.7 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.7 | 6.7 | GO:0019003 | GDP binding(GO:0019003) |
0.7 | 8.9 | GO:0050661 | NADP binding(GO:0050661) |
0.7 | 3.7 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.7 | 3.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.7 | 2.9 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.7 | 8.8 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.7 | 2.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.7 | 0.7 | GO:0008142 | oxysterol binding(GO:0008142) |
0.7 | 2.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) calcium:cation antiporter activity(GO:0015368) |
0.7 | 3.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.7 | 1.4 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.7 | 1.4 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.7 | 15.6 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.7 | 1.4 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.7 | 3.5 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.7 | 21.6 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.7 | 4.2 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.7 | 2.1 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.7 | 11.1 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.7 | 2.8 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.7 | 1.4 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.7 | 4.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.7 | 15.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.7 | 2.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.7 | 1.4 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.7 | 2.7 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.7 | 21.1 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.7 | 10.2 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.7 | 45.9 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.7 | 2.0 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.7 | 0.7 | GO:0036033 | mediator complex binding(GO:0036033) |
0.7 | 6.7 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.7 | 6.0 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.7 | 2.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.7 | 2.0 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.7 | 0.7 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.6 | 1.9 | GO:0045182 | translation regulator activity(GO:0045182) |
0.6 | 18.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.6 | 3.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.6 | 1.9 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.6 | 3.8 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.6 | 8.8 | GO:0005504 | fatty acid binding(GO:0005504) |
0.6 | 0.6 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.6 | 1.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.6 | 1.9 | GO:0008430 | selenium binding(GO:0008430) |
0.6 | 1.9 | GO:0019002 | GMP binding(GO:0019002) |
0.6 | 3.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.6 | 0.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.6 | 3.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.6 | 2.4 | GO:0030515 | snoRNA binding(GO:0030515) |
0.6 | 4.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.6 | 1.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.6 | 12.6 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.6 | 2.4 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.6 | 27.3 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.6 | 13.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.6 | 2.4 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.6 | 0.6 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.6 | 2.3 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.6 | 1.2 | GO:0043426 | MRF binding(GO:0043426) |
0.6 | 11.7 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.6 | 11.0 | GO:0035326 | enhancer binding(GO:0035326) |
0.6 | 6.4 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.6 | 16.8 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.6 | 8.6 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.6 | 2.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.6 | 1.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.6 | 2.8 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.6 | 1.1 | GO:0000182 | rDNA binding(GO:0000182) |
0.6 | 282.6 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.6 | 1.1 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.6 | 1.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.6 | 2.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.6 | 0.6 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.6 | 2.8 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.6 | 1.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.5 | 3.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.5 | 1.6 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.5 | 10.1 | GO:0043621 | protein self-association(GO:0043621) |
0.5 | 3.7 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.5 | 1.6 | GO:0019864 | IgG binding(GO:0019864) |
0.5 | 1.6 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.5 | 1.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.5 | 43.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.5 | 7.3 | GO:0022842 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.5 | 6.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.5 | 3.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.5 | 55.9 | GO:0003924 | GTPase activity(GO:0003924) |
0.5 | 5.5 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.5 | 0.5 | GO:0019863 | IgE binding(GO:0019863) |
0.5 | 4.0 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.5 | 2.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.5 | 1.0 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.5 | 2.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.5 | 6.9 | GO:0070888 | E-box binding(GO:0070888) |
0.5 | 3.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.5 | 2.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.5 | 10.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.5 | 1.8 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.5 | 1.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.5 | 30.7 | GO:0019902 | phosphatase binding(GO:0019902) |
0.4 | 22.9 | GO:0000149 | SNARE binding(GO:0000149) |
0.4 | 4.8 | GO:0016741 | transferase activity, transferring one-carbon groups(GO:0016741) |
0.4 | 36.9 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.4 | 0.4 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.4 | 0.8 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.4 | 0.8 | GO:0015923 | mannosidase activity(GO:0015923) |
0.4 | 3.7 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.4 | 3.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.4 | 3.7 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.4 | 0.4 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.4 | 0.8 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.4 | 2.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.4 | 0.4 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.4 | 4.7 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.4 | 1.5 | GO:0005113 | patched binding(GO:0005113) |
0.4 | 7.5 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.4 | 0.4 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.4 | 0.4 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.4 | 22.5 | GO:0016791 | phosphatase activity(GO:0016791) |
0.4 | 4.3 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.4 | 0.7 | GO:0070697 | activin receptor binding(GO:0070697) |
0.3 | 9.1 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.3 | 2.8 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.3 | 17.2 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.3 | 40.5 | GO:0061135 | endopeptidase regulator activity(GO:0061135) |
0.3 | 1.4 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.3 | 3.0 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.3 | 3.0 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.3 | 2.0 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.3 | 0.6 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.3 | 2.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.3 | 0.3 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.3 | 0.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.3 | 0.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 9.4 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.3 | 1.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 17.1 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.3 | 1.5 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.3 | 0.9 | GO:0043199 | sulfate binding(GO:0043199) |
0.3 | 1.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.3 | 0.3 | GO:0019808 | polyamine binding(GO:0019808) |
0.3 | 3.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.3 | 0.8 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.3 | 1.9 | GO:0003796 | lysozyme activity(GO:0003796) |
0.3 | 32.5 | GO:0016758 | transferase activity, transferring hexosyl groups(GO:0016758) |
0.3 | 0.3 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.3 | 0.3 | GO:0033265 | choline binding(GO:0033265) |
0.3 | 7.7 | GO:0005496 | steroid binding(GO:0005496) |
0.3 | 1.3 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.3 | 0.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 4.0 | GO:0051117 | ATPase binding(GO:0051117) |
0.2 | 0.2 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.2 | 1.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 0.5 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.2 | 11.5 | GO:0005262 | calcium channel activity(GO:0005262) |
0.2 | 1.0 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.2 | 0.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 0.5 | GO:0051431 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.2 | 0.9 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.2 | 24.3 | GO:0003723 | RNA binding(GO:0003723) |
0.2 | 4.8 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.2 | 0.6 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 0.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 19.6 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.2 | 0.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.2 | 29.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 0.8 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 3.9 | GO:0005254 | chloride channel activity(GO:0005254) |
0.2 | 0.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 3.4 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.2 | 0.9 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 0.2 | GO:0016896 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity(GO:0004532) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.2 | 1.9 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.2 | 0.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 1.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 0.5 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.2 | 0.3 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 1.8 | GO:0016407 | acetyltransferase activity(GO:0016407) |
0.1 | 0.1 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 15.7 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 1.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 1.7 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.1 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 3.2 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.1 | 140.2 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 0.3 | GO:0004675 | transmembrane receptor protein serine/threonine kinase activity(GO:0004675) |
0.1 | 0.2 | GO:0015108 | chloride transmembrane transporter activity(GO:0015108) |
0.1 | 2.6 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.1 | 1.7 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 1.4 | GO:0016757 | transferase activity, transferring glycosyl groups(GO:0016757) |
0.1 | 2.7 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.1 | 0.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.2 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.1 | 0.4 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.2 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 1.5 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.1 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 1.0 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.5 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.5 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 1.1 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 1.7 | GO:0020037 | heme binding(GO:0020037) |
0.1 | 0.1 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.0 | 0.7 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.4 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.0 | 1.1 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.0 | 4.7 | GO:0019900 | kinase binding(GO:0019900) |
0.0 | 0.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.3 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.0 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 66.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
3.5 | 106.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
3.2 | 100.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
3.2 | 25.6 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
3.1 | 6.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
3.1 | 31.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
2.8 | 39.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
2.7 | 8.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
2.5 | 7.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
2.4 | 12.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
2.4 | 4.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
2.3 | 36.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
2.3 | 9.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
2.3 | 74.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
2.2 | 24.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
2.2 | 8.7 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
2.2 | 86.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
2.1 | 12.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
2.1 | 38.0 | PID ARF 3PATHWAY | Arf1 pathway |
2.1 | 115.9 | PID E2F PATHWAY | E2F transcription factor network |
2.1 | 6.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
2.0 | 91.0 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
2.0 | 80.0 | PID PLK1 PATHWAY | PLK1 signaling events |
2.0 | 65.1 | PID LKB1 PATHWAY | LKB1 signaling events |
2.0 | 25.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.9 | 3.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
1.9 | 31.0 | PID MYC PATHWAY | C-MYC pathway |
1.9 | 20.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.9 | 15.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.9 | 100.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
1.9 | 31.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
1.8 | 3.6 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
1.8 | 14.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
1.8 | 5.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
1.7 | 31.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
1.7 | 24.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
1.7 | 10.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
1.7 | 35.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
1.7 | 30.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
1.7 | 38.4 | PID ATR PATHWAY | ATR signaling pathway |
1.6 | 27.1 | PID BARD1 PATHWAY | BARD1 signaling events |
1.6 | 55.3 | PID P73PATHWAY | p73 transcription factor network |
1.6 | 45.6 | PID P53 REGULATION PATHWAY | p53 pathway |
1.6 | 7.8 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
1.6 | 21.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
1.5 | 18.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
1.5 | 16.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.5 | 4.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
1.5 | 66.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
1.5 | 11.7 | PID EPO PATHWAY | EPO signaling pathway |
1.5 | 26.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
1.4 | 12.9 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
1.4 | 4.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.4 | 37.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
1.4 | 26.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
1.4 | 16.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
1.3 | 41.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
1.3 | 32.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.3 | 22.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
1.3 | 25.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
1.3 | 23.7 | PID RHOA PATHWAY | RhoA signaling pathway |
1.3 | 9.2 | PID IFNG PATHWAY | IFN-gamma pathway |
1.3 | 24.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
1.3 | 9.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
1.2 | 11.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
1.2 | 9.7 | PID FOXO PATHWAY | FoxO family signaling |
1.2 | 19.2 | PID ARF6 PATHWAY | Arf6 signaling events |
1.2 | 5.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.2 | 2.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.1 | 1.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
1.1 | 17.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
1.1 | 25.3 | PID CDC42 PATHWAY | CDC42 signaling events |
1.0 | 15.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
1.0 | 12.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.0 | 10.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
1.0 | 6.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
1.0 | 11.5 | PID INSULIN PATHWAY | Insulin Pathway |
1.0 | 61.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.9 | 21.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.9 | 3.6 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.9 | 10.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.8 | 14.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.8 | 8.9 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.8 | 9.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.7 | 1.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.7 | 10.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.7 | 13.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.7 | 0.7 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.7 | 0.7 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.7 | 10.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.7 | 3.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.7 | 5.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.6 | 7.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.6 | 6.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.6 | 2.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.6 | 19.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.5 | 5.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.5 | 1.6 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.5 | 6.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.5 | 5.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.5 | 11.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.5 | 2.8 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.4 | 9.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.4 | 2.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.4 | 6.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 2.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.4 | 0.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 5.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.3 | 3.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.3 | 6.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.3 | 1.0 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.3 | 2.0 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 2.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 3.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 1.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 2.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 1.8 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 3.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 2.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 0.5 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 0.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.8 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 1.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.6 | 78.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
5.5 | 65.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
4.2 | 21.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
4.2 | 66.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
3.9 | 42.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
3.8 | 37.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
3.7 | 40.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
3.6 | 28.9 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
3.5 | 39.0 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
3.5 | 35.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
3.5 | 38.7 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
3.3 | 33.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
3.3 | 56.5 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
3.1 | 28.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
3.1 | 43.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
3.1 | 21.4 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
3.0 | 15.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
3.0 | 142.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
3.0 | 3.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
3.0 | 23.8 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
3.0 | 50.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
3.0 | 44.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
3.0 | 62.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
2.9 | 61.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
2.9 | 2.9 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
2.9 | 80.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
2.9 | 17.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
2.8 | 16.9 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
2.8 | 58.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
2.7 | 2.7 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
2.7 | 2.7 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
2.7 | 32.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
2.7 | 48.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
2.7 | 56.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
2.6 | 34.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
2.6 | 13.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
2.6 | 2.6 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
2.6 | 43.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
2.6 | 33.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
2.5 | 50.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
2.5 | 17.6 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
2.5 | 5.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
2.5 | 39.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
2.5 | 22.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
2.5 | 24.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
2.4 | 43.9 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
2.4 | 24.0 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
2.4 | 33.6 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
2.4 | 2.4 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
2.4 | 16.6 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
2.4 | 9.5 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
2.4 | 26.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
2.4 | 85.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
2.4 | 61.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
2.2 | 60.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
2.2 | 99.1 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
2.2 | 15.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
2.2 | 13.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
2.2 | 19.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
2.2 | 32.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
2.2 | 43.0 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
2.2 | 17.2 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
2.1 | 8.5 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
2.1 | 10.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
2.1 | 38.0 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
2.1 | 16.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
2.0 | 6.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
2.0 | 60.5 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
2.0 | 17.9 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
2.0 | 15.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
2.0 | 9.8 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
2.0 | 35.1 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.9 | 99.3 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
1.9 | 1.9 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
1.9 | 3.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
1.9 | 101.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.9 | 22.9 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
1.9 | 3.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.9 | 16.7 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
1.9 | 40.7 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
1.8 | 18.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
1.8 | 10.9 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
1.8 | 45.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
1.8 | 54.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.8 | 37.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
1.8 | 7.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
1.8 | 7.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
1.7 | 26.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
1.7 | 34.9 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
1.7 | 13.9 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
1.7 | 8.7 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
1.7 | 12.2 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
1.7 | 19.1 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
1.7 | 13.9 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
1.7 | 8.6 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
1.7 | 13.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
1.7 | 24.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.7 | 28.7 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
1.7 | 11.8 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
1.7 | 15.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
1.7 | 208.8 | REACTOME TRANSLATION | Genes involved in Translation |
1.6 | 27.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
1.6 | 70.1 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
1.6 | 3.3 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
1.6 | 19.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.6 | 25.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
1.6 | 19.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
1.6 | 8.0 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
1.6 | 17.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
1.6 | 9.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
1.6 | 6.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.5 | 1.5 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
1.5 | 39.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
1.5 | 19.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.5 | 15.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.5 | 22.8 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
1.5 | 18.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
1.5 | 39.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.5 | 16.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
1.5 | 11.7 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
1.5 | 4.4 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
1.4 | 24.5 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
1.4 | 25.7 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
1.4 | 14.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
1.4 | 12.6 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
1.4 | 9.7 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
1.4 | 13.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
1.4 | 19.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
1.4 | 6.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.4 | 9.6 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
1.3 | 12.1 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
1.3 | 13.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
1.3 | 35.9 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
1.3 | 21.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.3 | 25.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
1.3 | 17.1 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
1.3 | 7.9 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
1.3 | 6.5 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
1.3 | 9.0 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
1.3 | 34.7 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
1.3 | 29.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
1.3 | 6.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
1.3 | 7.6 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
1.3 | 149.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
1.3 | 45.2 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
1.3 | 20.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
1.2 | 36.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
1.2 | 2.4 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
1.2 | 8.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
1.2 | 4.8 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
1.2 | 10.7 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
1.2 | 1.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
1.2 | 15.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
1.2 | 1.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.1 | 3.4 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
1.1 | 12.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
1.1 | 5.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
1.1 | 25.6 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
1.1 | 5.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
1.1 | 12.2 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
1.1 | 24.3 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
1.1 | 11.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
1.1 | 8.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
1.1 | 5.5 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
1.1 | 13.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
1.1 | 11.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
1.1 | 78.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
1.1 | 9.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.1 | 2.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
1.1 | 8.5 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
1.0 | 1.0 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
1.0 | 11.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
1.0 | 4.1 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
1.0 | 10.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
1.0 | 14.4 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
1.0 | 4.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
1.0 | 2.0 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
1.0 | 3.9 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
1.0 | 6.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
1.0 | 57.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.9 | 22.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.9 | 14.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.9 | 11.0 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.9 | 72.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.9 | 70.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.9 | 11.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.9 | 1.8 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.8 | 8.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.8 | 10.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.8 | 11.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.8 | 9.5 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.8 | 2.4 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.8 | 10.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.8 | 11.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.8 | 1.6 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.8 | 0.8 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.8 | 4.5 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.7 | 5.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.7 | 8.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.7 | 6.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.7 | 21.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.7 | 5.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.7 | 8.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.7 | 0.7 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.7 | 10.3 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.7 | 1.4 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.7 | 20.9 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.7 | 4.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.7 | 3.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.7 | 0.7 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.6 | 1.9 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.6 | 1.9 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.6 | 36.2 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.6 | 9.8 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.6 | 6.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.6 | 0.6 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
0.6 | 5.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.6 | 20.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.6 | 2.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.5 | 7.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.5 | 1.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.5 | 16.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.5 | 0.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.5 | 4.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.5 | 3.5 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.5 | 3.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.5 | 11.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.4 | 0.4 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.4 | 0.4 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.4 | 2.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.4 | 2.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.3 | 4.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.3 | 6.5 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.3 | 3.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 2.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.3 | 1.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 5.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.3 | 9.2 | REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION | Genes involved in Post-translational protein modification |
0.2 | 0.2 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.2 | 0.7 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.2 | 8.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 3.6 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.2 | 3.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 0.3 | REACTOME MEMBRANE TRAFFICKING | Genes involved in Membrane Trafficking |
0.2 | 1.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 2.6 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 0.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 0.4 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.1 | 0.4 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 1.0 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 1.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.6 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 1.7 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
0.1 | 0.3 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.0 | 4.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.3 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.0 | 0.2 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.8 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.0 | 0.4 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |